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ABSTRACT 
 
Functionalization of Poly(Ethylene Oxide)-based  
Diblock Copolymer Vesicles. (May 2010) 
Karym Grace Kinnibrugh García, B.S., Pontificia Universidad Católica del Perú 
Chair of Advisory Committee: Dr. Zhengdong Cheng 
 
The principal goal of this research is to achieve the chemical labeling and surface 
modification of block copolymer vesicles (polymersomes) made from amphiphilic 
diblock copolymer Poly(butadiene-b-ethylene oxide) (PBd120- PEO89, MW 10400 g/mol) 
with the aim of developing possible drug carrier vehicles for controlled release of 
molecules triggered by stimuli-responsive environments. 
The terminal hydroxyl group of poly(ethylene oxide) (PEO), or poly(ethylene 
glycol) is converted into its corresponding carboxylic acid by a novel one-pot two-phase 
oxidation reaction. This regioselective and catalytic reaction assures the preservation of 
important structural characteristic of the block copolymers. Vesicles formed by a 
mixture of the carboxylate and unmodified block copolymer exhibit an increment in the 
critical aggregation concentration (CAC) value while the averaged vesicle size decreases 
demonstrating that the negative charges in the modified diblock copolymer disrupt the 
vesicle formation process. 
The carboxylated reactive intermediates are subsequently subjected to a covalent 
coupling reaction in organic solvent to replace the terminal hydroxyl of the PEO block. 
 iv 
The obtained functionalized diblock copolymers are effectively incorporated into the 
vesicle bilayer. Also, surface density control in polymersomes of fluorescently modified 
diblock copolymers, synthesized by the amination reaction, is achieved. 
To demonstrate the ability of this polymersomes as carrier vehicles, a 
Noradrenaline functionalized vesicle is placed in closed contact with rat aortic smooth 
muscle cells (RASMC) using the micropipette aspiration technique. A distinctive 
increase in fluorescent intensity of cells is observed. It indicates that the drug molecule 
has been transported by the polymersome and internalized by the cell. In addition, 
diblock copolymers containing a disulfide moiety and a fluorophore are synthesized and 
studied through fluorescent microscopy. Vesicles are formed with this polymer and a 
decrease in fluorescent intensity is observed in the vesicle‟s bilayer after its exposure to 
a reductive environment. These results indicate that fluorophore molecules are 
successfully released into solution. 
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CHAPTER I 
 
INTRODUCTION 
 
1.1 Overview 
Over the years, many traditional drug therapies have failed to perform efficiently 
and in several cases the side effects of the administered drug caused more distress to the 
patience. In order to reduce the possibility of under and overdosing, among other 
possible life-threatening situations, polymeric vesicles arise as promising controlled-
release drug delivery vehicles (see Figure 1.1). 
Ideally, polymeric vesicles will help to keep constant the required drug level in 
the body, fewer doses will be required, effective retention of different encapsulates will 
be accomplish and specific triggered and controlled release of contents will be achieved. 
However, other design considerations are still complicated to incorporate into the 
vesicle‟s architecture such as biocompatibility, biodegradability over suitable periods of 
time, extended blood circulation, and non-toxic byproducts. In summary, this attractive 
devices need to be functionalized and tailored for specific uses and subjects. Thus, 
functionalization of polymeric vesicles is still of significant interest for the scientific 
community. 
 
 
____________ 
This dissertation follows the style of Biomaterials. 
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Figure 1.1 Schematic representation of drug levels in blood stream in (a) traditional drug 
administration and dosage and (b) controlled delivery dosage. (a) Drug dosing can fall below or 
above the required treatment level in between the multiple doses required which can produce life 
threatening situations for the patient. (b) Using controlled drug delivery, a single dose can keep 
steady levels of drug in blood. 
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1.2 Phospholipids and Cell Membrane Composition 
During the last century, it has been realized that all living matter is composed of 
cells, that cells are organized into compartments, and that cell walls are composed of 
bilayers of lipid molecules [1-4]. Natural phospholipid molecules found in cell 
membranes are amphiphilic molecules of molecular weight less than 1 kilodalton with 
one water-soluble end and one hydrophobic end. The water-soluble end is usually 
charged while the hydrophobic end is usually one or more hydrocarbon chains. The 
lipids found in cell membranes are mostly molecules with two hydrocarbon chains of 
about 10 carbons. 
When phospholipids are suspended in water they can form a variety of structures 
but in all cases the hydrophilic phosphate region interacts with water and the 
hydrophobic fatty acid regions are excluded to form hydrophobic interactions. This self-
directed assemble is possible because the charged ends of the phospholipids have lower 
free energy when in contact with the surrounding water while the opposite is true for the 
hydrocarbon tails. The latest ones eliminate most of their contact with water if they 
organize themselves into bilayers of about 5 nm and, when closed into “bubble type 
structures”, bilayers provide a barrier between inside and outside defining closed 
compartments. Large bubbles of this type with many microns in diameter are called 
vesicles or liposomes [5-14]. 
 
 
 
 4 
1.3 Lipid Vesicles and Biological Membranes 
The discovery of liposomes is credited to A.D. Bangham while performing 
research on blood cloths in 1961 [15]. Bangham first observed that in aqueous solutions, 
phospholipids spheres were formed and he cited: “Liposomes are the smallest artificial 
vesicles of spherical shape that can be produced from natural nontoxic phospholipids 
and cholesterol. Liposomes are microscopic, fluid-filled pouches whose walls are made 
of layers of phospholipids identical to the phospholipids that make up cell membranes”. 
Since 1811, research reports described the binding of phosphorous molecules to fatty 
acid chains, presence of lipid-like substances in biological samples and, growth of 
cylindrical structures from lipids extracted from brain tissue. Still, it was not until the a 
hundred years later when the introduction of the electron microscope helped with the 
characterization of close packed lipid structures [16-18].  
However, it was not until the 1970‟s that the potential use of lipid vesicles as 
packaging agents and drug delivery systems was recognized [19-22]. During 1980‟s, 
distribution of injected liposomes formulations by the circulatory system was the main 
focus of this research area [23-31], and throughout 1990‟s, gene therapy and gene 
diagnosis applications of liposomes prevail [30, 32]. On the other hand, the relative 
success of lipid vesicles as drug delivery vehicles contrasts with the difficult control of 
lipid properties when long-standing use is required such as, lipid stability in biological 
fluids, long-term storage and cell targeting. Lipid vesicles play an important role in cell 
function as compartmentalizing structures, nutrient transport facilitators, DNA protective 
agents, and they can entrap dissolved substances as well as hydrophilic and hydrophobic 
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compounds inside the membrane cores. Due to the dynamic and soft character of lipids 
[33-35], when more than 100x103 amphiphiles aggregate into a membrane, properties 
such encapsulant retention ability, membrane stability and degradation become difficult 
to control [36-38]. For that reason, a polymer mimic of lipid ones emerged as an 
alternative since its structure resembles that of a living cell. Polymer vesicles will also 
help to take a closer look to the principles of natural design of biological membranes and 
membrane mediated events [39-42]. 
 
1.4 Polymersomes: A Polymer Mimic of Lipid Vesicles  
 Small amphiphilic molecules such as lipids have inspired the use of synthetic 
analogs of higher molecular weight defined as super amphiphiles, category that includes 
linear diblock copolymers. In the last decades, an increase interest in the use of artificial 
block copolymers to produce cell-like vesicles, also called polymersomes, was reported 
because of their unique properties. These artificial bilayer structures can be formed by 
self-assembly of synthetic diblock copolymers and the produced synthetic vesicles 
exhibit superior material characteristics making them tougher than lipid vesicles [43-44]. 
 Block copolymers have similar design as phospholipids and these are formed by 
covalent linking of two (diblock copolymers) or more polymer segments that usually are 
much larger than the lipid ones [45-47]. In the presence of a solvent, they will self 
assemble into different structure types determined by the hydrophilic-hydrophobic 
diblock ratio: membranes, micelles, rod-like or spherical vesicles (see Figure 1.2).  
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Figure 1.2 Schematic representation of natural phospholipids (a), microscopy image of 
PBd120PEO89 diblock copolymer vesicles (b), chemical structure of PBdmPEOn diblock 
copolymer (c), and self-assembly of phospholipids and diblock copolymers into vesicle 
structures (d). Natural phospholipids and synthetic diblock copolymers consist of hydrophobic 
and hydrophilic segments; both will self-assemble in aqueous solution to form vesicles. 
 
The mechanical properties of polymersomes have been studied by micropipette 
aspiration technique. Their elastic, determined by measurement of membrane tension (τ, 
mN/M) versus area expansion (α = ΔA/A0), behavior was proved to be superior to that of 
lipid vesicles (see Figure 1.3). Its increased chain length provides toughness (determined 
by membrane aspiration to the point of rupture) and reduces membrane permeability 
(considerable reduced transport rate) which enable polymersomes as new artificial and 
resistant delivery vehicles [48-50]. The chemistry of these novel structures can be 
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manipulated by controlling the diblock molecular weight, block ratio, and architecture of 
the block copolymer used [51-53]. 
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Figure 1.3 Schematic representation of increased mechanical resistance of diblock copolymer 
vesicles compared to lipid vesicles. Polymer vesicles can stand greater mechanical deformations 
(~0.20 %) before rupture than lipid vesicles (~0.05%). 
 
Formation of Polymersomes 
Polymersomes can be formed from diblock copolymers where the hydrophobic 
region has a high glass transition temperature (Tg) like polystyrene (PS) and the 
hydrophilic part is ionic (like poly-(acrylic acid), PAA) or when the overall molecular 
weight of the diblock copolymer is higher than the one for lipids (much greater than 10 
kD) [54]. The general procedure of polymersome preparation includes the dissolution of 
the diblock copolymer in an appropriate solvent for both blocks (dioxane for PS-PAA 
case), a drying step that allow a thin polymer film formation (micrometers thick), and 
 ΔA/A0 
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addition of water to precipitate vesicles. Water promotes aggregation of PS and 
formation and increase of interfacial tension. This very last step, the rehydration of the 
polymer film, will introduce the key to the utilization of polymersomes as drug delivery 
vehicles (see Figure 1.4). Any water based solution containing drugs, proteins or any 
kind of molecule will be encapsulated inside the polymersome during the rehydrating 
step. Retention of captured molecules, such as dextrans, sucrose or physiological saline, 
have been proved to remain stable over periods of several months inside of 100 nm 
polymersomes and 10 m giant vesicles [55-56]. 
 
Polymer thin film
Polymer vesicles 
(1-50 μm)
Glass/Teflon
Aqueous 
solution
(a) (b) (c)
60oC 60oC
 
Figure 1.4 Formation of diblock copolymer vesicles in aqueous solution at 60ºC. Polymeric 
vesicles will spontaneously self-assemble in order to minimize the system‟s surface tension 
energy. (a) A thin polymer film was formed over a glass or Teflon® surface after a drying 
process. (b) An aqueous solution was added and heated overnight at 60ºC. (c) Diblock 
copolymer vesicles suspended in solution. 
 
Formation of polymersomes in aqueous solvents can also be accomplished. 
Extensive research has been done using polyethylene-b-polybutadiene (PEOm-PBdn), as 
well as it hydrogenated homolog polyethylene-b-polyethylethylene (PEOm–PEEn), to 
form vesicles under different aqueous environments. Doxorubicin, an anti-neoplastic 
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agent, was encapsulated during rehydration by the polymer vesicle with liposomes 
similar efficiency increasing the potential of using polymersomes as artificial controlled-
release systems. Other approaches on the use of polymersomes as synthetic drug 
delivery devices are reviewed in the following sections [57]. 
 
Applications of Polymersomes 
Triblock copolymers can also form polymersomes with some useful differences 
with respect to membrane properties. Pluronic®, a large triblock copolymer (PEO5-
PPO68-PEO5) composed of a large poly-(propyleneoxide) (PPO) midblock, forms small 
vesicles in water media with thin membranes of 3-5 nm and a short life of hours only, 
which will suggest that this midblock weaken the polymeric structure. Another example 
of vesicle forming triblock is composed of a hydrophobic midblock of poly-
(dimethylsiloxane) (PDMS) and two polar blocks of poly-(2-methyloxazoline) 
(PMOXA) with crosslinkable methacrylate ending groups. 
Block copolymers with a bioinert block and a hydrophilic block that can undergo 
hydrolytic degradation have been extensively studied as a possibility for in vivo 
biodegradable drug delivery polymersomes [58-60]. However, a new amphiphilic 
diblock copolymer system of PEO and poly-(caprolactone) (PCL), both of them used in 
FDA–approved medical devices, promise to form completely bioresorbable vesicles with 
no toxic byproducts as a result of its degradation. Again, PEO [57] was chosen because 
of its biocompatibility and also because it gives to the vesicles longer blood circulation 
times [61-62]. PCL will form the hydrophobic membrane portion of the vesicle. It 
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degrades safely and completely by hydrolysis of its ester bond under physiological 
conditions which makes itself a suitable implantable biomaterial for drug delivery 
vehicles. Among the advantages of PCL are: elevated permeability to small molecules, 
pH of the media is preserved after degradation, it mixes well with other polymers, and its 
slow degradation (by erosion mechanism) makes it appropriate for long-term drug 
delivery. Vesicles of 10-20 m diameter, ideal size for in vivo applications, were formed 
and size was controlled either by sonication or freeze/thaw technique followed by 
extrusion above 65°C. A wide range of PEO-b-PCL block copolymers with different 
molecular weights were studied being only PEO(2K)–b–PCL(12K) the one to give a 
good yield of vesicle formation via spontaneous self assembly [63]. 
Doxorubicin was dissolved in the aqueous solution of dehydration of PEO(2K)-
b- PCL(12K) polymersomes in order to elucidate the mechanism by which a drug is 
released. Doxorubicin in situ released under physiological conditions such as pH 5.5 and 
7.4, and 37°C was monitored fluorometrically for 14 days. At both pH conditions at 
37°C, an instantaneous burst release was registered (20 % of vesicle filling, from 0 to 8 
hours), proceeded by controlled release. The drug releasing process can be cataloged 
into two different steps: First the drug was released mainly by its diffusion through PCL 
membrane and although hydrolytic degradation of the PCL membrane is observed, it is 
not of much importance. A second drug release occurred due to significant hydrolytic 
PCL membrane degradation. At ph 7.4 the first and second types of drug release were 
observed while at pH 5.4 only the second type predominates. Hence, in vivo drug release 
of PEO(2K)-b-PCL(12K) is both dependent on PCL matrix erosion and drug‟s specific 
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permeability through the vesicle membrane. In comparison with polymersomes that 
undergoes hydrolytic degradation over a small period of time (hours), PEO(2K)-b-
PCL(12K) exhibits slower rates of drug releasing (days). 
Other functionalized self-assembly polymersomes includes copolymers of PEO – 
PPS (poly-(propylenesulfide)) where the PPS groups are susceptible to undergo 
oxidative degradation. PEO-PLA (poly-(lactide)) kilodalton-size block copolymers form 
micelles that can be biodegraded by hydrolytic scission raising the possibility of its use 
for controlled drug release.  Therefore, biodegradable vesicles for controlled drug release 
of its contents are feasible. 
Also, PEO-PEE polymersomes were injected into blood stream of rats and it was 
shown that they behave as liposomes. They circulated for 15-20 hours before being 
captured by phagocytes of liver. In a parallel test tube study in cell–free blood plasma, it 
was shown that plasma proteins slowly accumulate over the polymersome membrane 
followed by cell attachment. This effective delay was provided by the brush surface of 
the PEO which acts like a biomembrane. These results emphasize polymersomes as 
biomedical a promise. 
Thus, synthetic polymer vesicles can also mimic many biological membrane 
processes, such as protein integration, fusion and DNA encapsulation [64]. Polymer 
versatility regarding molecular weight, polydispersity, reactivity, and synthetic diversity 
provide a broad spectrum of approaches to vesicle design for drug delivery. However, 
actual polymersomes still exhibit a structural stability that relays on several intrinsic and 
environmental parameters which commonly ended up affecting its efficacy as drug 
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delivery vehicles [65]. The degradation periods are still not long enough for controlled 
long-term in vivo drug release and small periods of circulation time are considered as 
important drawbacks of this polymersomes design. Also, the absorption of 
macromolecular drugs such as peptides and proteins to polymersome walls and protein 
configuration changes caused by polymer interactions are other disadvantages of 
polymersomes still to be solved. 
General considerations for future polymersome designs for in vivo controlled 
drug delivery will include the biocompatibility and biodegradability of the hydrophobic 
component, extended degradable periods and extended circulation times in blood stream, 
and non-toxic degradation products that can be metabolized and excreted by the human 
body [66-67]. Not only exerted control over chain length of the block copolymers and 
ratio of amphiphile components are important for polymersome design but also, the 
molecular weight and polymer structure (linear or branched) should be controlled to 
explore the possibility of size and surface modifications. 
 
1.5 Dissertation Outline 
Chapter II: Oxidation of Primary Alcohol end Group of PBd120PEO89 Diblock 
Copolymer 
 The free hydroxyl terminal end group of the block copolymer Poly(butadiene-b-
ethylene oxide) (PEO89PBd120, MW 10400 g/mol) is oxidized to its 
corresponding carboxylic acid (carboxylate PBd120PEO89) through a  selective 
two phase oxidation reaction while other oxidizable groups remain unaffected. 
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 The CAC values of vesicle solutions containing a mixture of carboxylate 
PBd120PEO89 and unmodified PBd120PEO89 increase when the percentage of 
carboxylate PBd120PEO89 is increased, while the average vesicle size decreases. 
No vesicle formation is observed at concentrations higher than 80% are reached.  
Chapter III: Covalent Coupling of Primary Amine to Carboxylate PBd120-PEO89 
Diblock Copolymer 
 Three different primary amines were covalently attached to the previously 
synthesized carboxylate block copolymer through a modified amination reaction 
performed in organic phase. 
 Polymersomes containing 90% of the unmodified block copolymer and 10% of 
one of the modified block copolymers (PBd120PEO89-6AF, PBd120PEO89-COU, 
and PBd120PEO89-NA) were prepared. 
 Two types of modified diblock copolymers (PBd120PEO89-6AF, PBd120PEO89-
COU) were also properly integrated into the same vesicle and, surface density 
control of the two fluorophores was achieved and confirmed through 
fluorescence microscopy. 
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Chapter IV: Cell Response to Hormone Functionalized PBd120-PEO89 Diblock 
Copolymer 
 Noradrenaline molecules were transported from the surface of functionalized 
vesicles to smooth muscle cell surfaces. 
 A cell response was produced (increase in fluorescent intensity) after 
noradrenaline molecules bound to surface cell receptors. 
Chapter V: Reduction-Responsive Functionalized PBd120PEO89 Diblock Copolymer 
Vesicles 
 The functionalized reductive-responsive diblock copolymer PBd120PEO89-
cystamine-5-tetramethylrhodamine (5-TAMRA) was synthesized using a one-pot 
two-step reaction and was incorporated into polymersomes in a 10% amount. 
 The reductive character of the diblock was given by the presence of a disulfide 
linkage between the PEO block and the 5-TAMRA fluorophore molecule. 
 The diblock copolymer disulfide bonds were selectively reduced when exposed 
to tris(2-carboxyethyl)phosphine hydrochloride (TCEP) and the fluorophore 5-
TAMRA was released into solution causing a decrease in the vesicle‟s bilayer 
fluorescent intensity of 44 %. 
Chapter VI: Conclusions and Future Directions 
In this dissertation research, the modification of polymersomes‟ surface by the 
introduction a functionalized diblock copolymer into the vesicle‟s bilayer was achieved. 
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Three functionalized PEO-PBd diblock copolymers were created using novel and simple 
synthetic pathways; they were effectively incorporated into the vesicle structure and 
characterized by microscopy techniques. Vesicle surface properties were studied and the 
polymersome‟s ability to deliver a drug molecule was tested using in vitro cell cultures. 
Hence, these studies contribute to the better understanding of functionalized diblock 
copolymer vesicles and its application as drug delivery devices. 
For future studies, biodegradable diblock copolymers may be used instead and 
apply to it the synthesis explored during this research. Investigate the cell internalization 
process and degradation time to elucidate the cell‟s response mechanism. Also, stimuli-
responsive functionalized polymersomes vulnerable to reducible atmospheres might be 
evaluated in contact with smooth muscle cell cultures to establish the reductive strength 
of the cytoplasmic environment over the disulfide moieties employed. 
A reductive destabilization mechanism involving a phase transition from vesicle 
to micelle of a PEO-PBd diblock copolymer linked to a second PEO block by a 
cystamine molecule can be synthesized and polymersomes containing this PEO-PBd-
cystamine-PEO amphiphillic polymer might be formed and studied. 
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CHAPTER II 
 
OXIDATION OF PRIMARY ALCOHOL END GROUP OF  
PBd120PEO89 DIBLOCK COPOLYMER 
 
2.1 Overview 
 The carboxylate derivative of the diblock copolymer polybutadiene-b-
poly(ethylene oxide) (PBd120PEO89, MW 10400 g/mol), (2), was prepared by a one pot 
two-phase oxidation reaction. This mild and regioselective catalytic reaction effectively 
oxidize only the primary alcohol end group of the polyethylene oxide block leaving 
unaffected any other susceptible groups, such as ether linkage of polyethylene oxide or 
C=C double bonds of the polybutadiene block. Vesicles containing the carboxylate 
derivatives were formed and the critical aggregation concentration (CAC) values of the 
vesicle solutions were measured. 
 
2.2 Introduction 
Due to PEO unique properties and applications the functionalization of PEO has 
been the focus of many researches [68-71]. However, the conversion of its free terminal 
hydroxyl group into an aldehyde or carboxylic acid has not been completely successful 
and many reaction procedures have been proposed. For example, the use of pyridine 
chlorochromate or dichlorochromate, suggested by Corey [72], affects other oxidizable 
groups of the polymer chain, such as carbon-carbon double bonds and ether linkages, 
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because a strong reaction condition was used and, hence only limited yields were 
obtained. A more selective and mild reaction was proposed by Kornblum [73] to use 
dimethyl sulfoxide as the oxidation reagent. Also, Mosbach [74-76] suggested the use of 
organic sulfonyl chlorides (tosyl and tresyl chloride), which formed good leaving groups 
that facilitates the formation of the respective carbonyl derivative. Nevertheless, the 
reaction conditions were still not easy to achieve and it was still not possible to 
discriminate between the oxidation of primary and secondary alcohol groups when 
present in the same molecule. Later on, Anelli [77-78] and coworkers suggested the use 
of 4-methoxy-2,2,6,6-tetramethyl-piperidine-1-oxyl (TEMPO), a nitroxyl radical 
catalyst, to regioselectively oxidize primary alcohol groups as a mild and 
environmentally friendly catalytic method. 
Herein, we propose a strategic synthesis to convert the primary hydroxyl end 
group of PBd120PEO89 diblock copolymer into its corresponding carboxylic acid using a 
modified version of the Anelli‟s protocol. This oxidation reaction was performed using a 
two phase (dichloromethane and water) system where TEMPO is continuously 
regenerated in the aqueous phase; in conjunction with a sodium hypochlorite (NaOCl) 
solution to regioselectively oxidize the free primary alcohol group of the block 
copolymer leaving intact any other groups. 
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Figure 2.1 Catalytic cycle of TEMPO during oxidation reaction of a primary alcohol (c) to the 
respective carboxylic acid (f). Figure 2.1.I shows that TEMPO (a) was first oxidized by NaClO 
to its respective N-oxoammonium salt (b); this oxidized the primary alcohol end group of the 
PEO block (c) to its aldehyde (d) in the organic phase while (b) is also regenerated. Figure 2.1.II 
shows that (d) returned to the catalytic cycle (aqueous phase) to further oxidize the aldehyde in 
its respective carboxylic acid (f). 
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Figue 2.1 shows the TEMPO catalytic cycle where it (a) was first oxidized by 
NaOCl to the respective N-oxoammonium salt (b), the primary alcohol end group of the 
PEO block (c) was oxidized to aldehyde (e) by the N-oxoammonium salt, and a 
molecule of the hydroxylamine (d) was produced. The aldehyde (e) was then oxidized 
by NaClO to carboxylic acid (f) and a molecule of NaOCl was regenerated [71, 79-83]. 
This formulation uses the oxidation agent NaOCl only, no addition of potassium 
bromide or quaternary ammonium salt (suggested by Anelli‟s protocol) was required, 
and it was performed at room temperature for 3-5 minutes. This constitutes an 
environmentally friendly catalytic method executed via mild conditions and less harmful 
chemicals. 
Figure 2.2 sketches the chemical structures of the diblock copolymer 
polybutadiene-b-poly(ethylene oxide) (PBd120PEO89) used as a starting material (1) and 
its oxidized derivative where the free hydroxyl end group is converted into the 
corresponding carboxylic acid, carboxylate PBd120PEO89 diblock copolymer (2). 
 
 
 
 
 
 
 
Figure 2.2 Oxidation reaction of primary alcohol end group of polybutadiene-b-poly(ethylene 
oxide) (PBd120PEO89) diblock copolymer. A carboxylate PBd120PEO89 diblock (2) is produced. 
 
(2) (1) 
NaOCl,TEMPO
RT, 40 min
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Once the carboxylate block copolymer is obtained, the critical aggregation 
concentration (CAC) [84] of vesicles formed by a blend of  varying  ratios of unmodified 
PBd120PEO89 and carboxylate PBd120PEO89 will be measured in order confirm the 
presence of the carboxylate derivative and to physically characterize the new product. 
 
2.3 Materials 
Poly(butadiene-b-ethylene oxide) (PBd120-PEO89, MW 10400 g/mol) block 
copolymer and sucrose (ACS reagent) (C12H22O11, MW 342.3 g/mol) were purchased 
from Polymer Source Inc. (Canada) and Fisher Scientific (Pittsburgh, PA), respectively. 
Dichloromethane (anhydrous, 99.9%) (CH2Cl2, MW 84.93 g/mol), chloroform (99.8+% 
for analysis ACS, stabilized with ethanol) (CHCl3, MW 119.38 g/mol) and methanol 
(99.8+% for analysis ACS) (MeOH, MW 32.04 g/mol) were purchased from Acros 
Organics (Morris Plains, NJ). 4-methoxy-2,2,6,6-tetramethyl piperidine-1-oxyl 
(TEMPO, 156.25 MW g/mol); sodium hypochlorite (NaOCl, MW 74.44 g/mol); sodium 
bicarbonate (NaHCO3, MW  84.01 g/mol), potassium chloride (KCl, MW 74.55 g/mol)  
and sodium hydroxide (NaOH, MW 40.00 g/mol) were purchased from Sigma-Aldrich 
(St. Louis, MO). Regenerated cellulose dialysis tubing kit (MWCO 8000 g/mol) was 
purchased from Spectra/Por®Biotech. 
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2.4 Experimental Methods 
Diblock Copolymer Characterization 
IR Spectroscopy. IR spectra of neat liquids were performed using a Bruker FT-IR 
TENSOR™ spectrometer (Billerica, MA) equipped with OPUS™ measurement software. 
Potassium bromide salt plates (McCarthy Scientific Co., Fallbrook, CA) and CH2Cl2, or 
CHCl3, were used to evaluate the polymer samples. 
 
Vesicle Solution Characterization 
Conductivity Measurements. A series of 11 vesicle solutions were prepared by 
mixing PEO89-PBd120 and carboxylate PEO89-PBd120 in ratios from 0:1 to 1:0 
respectively. The conductivities of each original sample and its correspondent 
subsequent dilutions (12-15 dilutions) were recorded using a Mettler Toledo pH meter 
(S20 SevenEasyTM, Columbus, OH), with a calibrated cell constant, and a Mettler 
Toledo pH microelectrode (InLab® 423). Ultra pure water (18.2 M-cm) was used to 
prepare the vesicle solutions and to dilute them. Potential measurements (mV) for each 
sample, expressed as conductivity values (μS/cm), were plotted against the respective 
polymer concentration (μM) in order to find the critical aggregation concentration 
(CAC) value of the sample. 
Microscope Imaging. Vesicle solutions were imaged using a temporary closed 
sample chamber constructed using a microscope slide, microscope glass cover, a silicone 
rubber and vacuum grease. In order to provide adequate contrast for imaging, a 310 
mOsm/kg NaCl solution was placed into the temporary chamber followed by a smaller 
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amount of the vesicle solution under study (300 mOsm/kg). Phase contrast images of 
polymersomes were taken by a Carl Zeiss Axiovert 200M inverted microscope with 100 
W HBO Mercury vapor lamp coupled to a Zeiss AxioCam MRm camera and a 20X 
objective (numerical aperture of 0.5).  
 
2.5 Synthesis of Carboxylate PBd120PEO89 
 A 20 mL reaction flask was charged with 1 mL of a CH2Cl2 solution of 
PBd120PEO89 diblock copolymer (MW 10400 g/mol), 1.38 mL of a 0.016M CH2Cl2 
solution of TEMPO and 5.72 mL of a 0.35 M aqueous sodium hypochlorite (NaOCl) 
solution buffered with NaHCO3 at pH 8.6. The reaction mixture was magnetically stirred 
at 900 rpm using a Teflon-covered stir bar. Doses of 1 mL of 0.016 M CH2Cl2 solution 
of 4-methoxy-2,2,6,6-tetramethyl piperidine-1-oxyl (TEMPO) were added every 3-5 min 
at room temperature. Once the reaction was completed, pH was adjusted at ≥ 11 with 
aqueous 3N NaOH in order to breakdown the formed emulsion. The organic phase was 
separated from the mixture and dried out in a vacuum oven. After the cleaning 
procedure, the final product was dried out in a vacuum oven and redisolved in CH2Cl2. 
An aliquot of the reaction solution was evaporated on a NaCl plate and the IR spectrum 
was obtained. 
 
Synthesis of (2) 
PBd120-PEO89 (40.0 mg, 3.85x10-3 mmol), TEMPO (13.22 mg, 8.46x10-2 mmol), 
and NaOCl (97.46 mg, 1.31 mmol) were reacted in dichloromethane/water as described 
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above. In this manner, product 1 (30.4 mg, 76% yield) was obtained. IR (ν): 1725 (C=O) 
cm-1. 
 
Functionalized Diblock Copolymer Cleaning Procedure 
The desired product, contained in the organic phase, was redisolved in 2 mL of a 
1:1 MeOH:CHCl3 solution and cleaned using regenerated cellulose dialysis tubing 
(MWCO 8000 g/mol). The sample was dialyzed for 2 hours at room temperature against 
600 mL (300 times the volume of the sample) of 1:1 MeOH:CHCl3 solution, the dialysis 
buffer was changed and the sample dialyzed for another 2 hours. Finally, the dialysis 
buffer was changed for the second time and the sample dialyzed overnight. 
 
2.6 Vesicle Solution Preparation 
A polymer film containing 100 μg of the desired block copolymer or block 
copolymer mixture was formed by evaporation (8 hours) at the bottom of a 5 mL glass 
scintillation vial. Polymersomes were formed by rehydration of this polymer film during 
24 hours at 60ºC with 2 mL of the desired solution: ultrapure (for conductivity 
measurements only) water or 300 mOsm/kg sucrose solution (osmometer model 3320, 
Advanced Instruments, Inc., Norwood, MA). In the case of vesicles formed with a 
mixture of block copolymers, X% w/w of carboxylate PBd120-PEO89 block copolymer 
was ideally mixed with Y% w/w of unmodified PBd120-PEO89 block copolymer before 
the polymer film formation step. Vesicle solutions of the mixture compositions shown in 
Table 2.1 were formed. 
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Table 2.1 Vesicle solution compositions of unmodified PBd120PEO89 and carboxylate PBd120-
PEO89 mixtures used for CAC measurements. 
Vesicle 
% w/w 
unmodified 
% w/w 
carboxylate 
Solution
* 
PBd120PEO89 PBd120PEO89 
1 100 0 
2 90 10 
3 80 20 
4 70 30 
5 60 40 
6 50 50 
7 40 60 
8 30 70 
9 20 80 
10 10 90 
11 0 100 
*The final block copolymer concentration in a 2 mL vesicle solution is 4.8 μM. 
 
Measurement of CAC of Vesicle Solutions 
CAC values can be determined by measuring the surface tension, conductivity, 
surfactant ion exchange, or ultraviolet absorbance of a copolymer solution due to a 
drastic change in these physical properties at the CAC. We determined the CAC‟s of the 
mixtures by conductivity measurements to locate the concentration where the 
conductivity rapidly plateaus.  
The solution voltage was measured by a pH meter and Ohm‟s Law (V  IR) was 
used to convert voltage into resistance and afterward, resistance (R) into conductance 
(G). Conductivity differs from conductance by a proportional factor which is specific to 
the apparatus. This factor was determined by measuring experimental conductance 
values of KCl solutions that were plotted against literature conductivity values [85]. 
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Conductivity was plotted against diblock copolymer concentration values. As the 
concentration increased, the conductivity values increased rapidly and, when the critical 
aggregation concentration (CAC) was reached, the conductivity plateaus. This point was 
identified by the intersection of the best linear fit of the two data regions on the 
conductivity-concentration plot. The experimental CAC values obtained were plotted 
against carboxylate PBd120PEO89 concentration and, CAC values were also modeled by 
iterating equation 12 and substituting the resulting x1 values into equation 6 [43, 86-88]. 
 
2.7 Results and Discussion 
Synthesis of Carboxylate PBd120PEO89 
The two-phase regioselective oxidation reaction successfully produced and a 
76% yield was obtained. A distinctive C=O transmittance band was observed at 1725 
cm-1 in the respective IR spectra contrasting with the starting material one. 
 
Verification of Composition of Carboxylate PBd120PEO89 
One of the main concerns regarding this oxidation procedure is to preserve other 
groups that is present in the polymer chain, such as the C=C and C-H bonds of the 
butadiene block and the C-O bond of the polyethylene oxide block, since they are also 
susceptible to oxidation. Figure 2.3 shows the overlay IR spectra of the unmodified 
PBd120PEO89 and the carboxylate PBd120PEO89. The presence of a peak at around 1725 
cm-1 in the carboxylate PBd120PEO89 IR spectra corresponding to a carbonyl stretch 
demonstrates that the oxidation of the free terminal hydroxyl group of PBd120PEO89, first 
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to an aldehyde and then to a carboxylic acid. The original characteristic peaks are 
preserved (C-H, C=C and C-O stretches) meaning that other groups present in the 
original diblock copolymer were not oxidized. 
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Figure 2.3 Comparison between the IR spectra of the unmodified PBd120PEO89 (top) and the 
carboxylate PBd120PEO89 (bottom). The carbonyl stretch (1725 cm-1) demonstrates that block 
copolymer was effectively oxidized to its carboxylic acid. 
 
CAC Measurements and Microscope Imaging 
Figure 2.4 shows the CAC values corresponding to PBd120PEO89 vesicle 
solutions formed with 0 to 100 percent of carboxylate PBd120PEO89. As the carboxylate 
PBd120PEO89 amount is increased, the CAC values increases while the average vesicle 
size decreases.  
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Figure 2.4 CAC of carboxylate PBd120PEO89 and unmodified PBd120PEO89 mixture. As the 
carboxylate PBd120PEO89 content is increased, the CAC increases and the averaged size of 
vesicles formed decreases. The solid line represents the theoretical CACmix values while the open 
dots represent the experimental values obtained. These two sets of values match until an 
approximate 80% of carboxylate PBd120PEO89 is present in the mixture. The scale bar in all 
pictures represents 10μm. 
 
 When the composition exceeds 80%, the CAC trend is disrupted and in contrast 
to the theoretical predicted ideal case (solid curve), the experimental values drop down 
close to the corresponding values of the unmodified block copolymer. The phase 
contrast images insets of Figure 2.4 indicate the decrease of the corresponding average 
vesicle size as the percentage of carboxylate PBd120PEO89 increases. In the 100% case no 
vesicle formation was observed. 
For aggregate formation, the transition between a single amphiphilic block 
copolymer (monomer) and a micelle (n-mer) can be considered in equilibrium, which is 
C
A
C
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μ
M
)
Percentage of Carboxylate PBd120PEO89  
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known as the mass action model or the pseudo-phase separation model. The chemical 
potential of component i can be calculated as following with i  for monomerically and 
ideally solubilized phase in solution and i
M for component i in a binary micelle [88-89]: 
 
Phase one (monomeric):  i  i
0  RT ln(Ci
m)           (1) 
 
Phase two (in micelle):  i
M  i
M0  RT ln( fi  xi )         (2) 
 
and,     i
M0  i
0  RT ln(Ci )           (3) 
 
where i
M0  is the chemical potential of component i in a homogenous aggregate, fi is the 
activity coefficient specifying the nonideality of the mixture, x i  is the mole fraction of 
copolymer i in the binary micelle, Ci
m  is the concentration of i in the solution, and Ci  is 
the critical micelle concentration of component i in solution. 
At phase equilibrium i  i
M
, which yields 
 
                                   xi 
Ci
m
fiCi
                                 (4) 
 
Since we have 
Ci
m iC
mix
      (5) 
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i.e., the CAC concentration of monomer i (Ci
m ) is equal to the mole fraction of polymer 
i in the mixture (i ) times the mixed CAC (C
mix ). This equation in combination with 
equation 4 and the relationship of mole fraction between components I =1,2 (1 x1  x2 ) 
yields 
 
1 
1C
mix 
f1C1

2C
mix 
f2C2
         (6) 
 
Since we are not dealing with an ideal binary mixture, the equations require the 
following activity coefficients: 
 
f1  exp (1 x1)
2             (7) 
 
f2  exp(x1
2 )            (8) 
 
where x1  carboxylate PBd120PEO89 and   is an empirical parameter that represents the 
intermolecular interaction between components 1 and 2. x i  can be found by 
minimization of the total Gibbs free energy for the micelle and the solutions are 
 
GN
M  Nx11
M  Nx22
M
          (9) 
 
GN  Nx11  Nx22           (10) 
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where N is the number of moles. Thus, the total change in free energy of the micelle 
during micellation is the potential difference between the micelle phase and the 
monomeric phase: 
 
GN
M  Nx1(1
M  1) Nx2(2
M  2)                          (11) 
 
After manipulation, the resulting equation 12 can be used to find the 
concentration of polymer 1 in the aggregate ( x1 ). 
 
ln
(1 x1)C2
x1C1





  (1 2x1) ln
11
1




       (12) 
 
After iterating equation 12 for x i , it is substituted into equation 6 to find the 
CACmix, which is plotted as a solid line in Figure 2.3. The β value [87] for carboxylated 
PBdPEO were adjusted until the calculated CAC values fit the data, β = -2.01. 
Below 80% of carboxylate PBd120PEO89 in the mixture, the experimental values 
confirm the theoretical prediction. After 80%, the CAC trend is disrupted and only very 
small vesicles are formed (unmodified polymer still present but in a very low 
concentration, less than 20%). This can be explained by the lower solubility of the 
carboxylate PBd120PEO89 which leads to their precipitation. 
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2.8 Conclusions 
The primary alcohol end group of a diblock copolymer is chemically modified 
and effectively combined with unmodified block copolymer to form stable 
functionalized polymeric vesicles.  The free hydroxyl terminal end group of the block 
copolymer Poly(butadiene-b-ethylene oxide) (PEO89PBd120, MW 10400 g/mol) is 
oxidized to its corresponding carboxylic acid (carboxylate PBd120PEO89) through a  
selective two phase oxidation reaction while other oxidizable groups remain unaffected. 
The CAC values of vesicle solutions containing a mixture of carboxylate 
PBd120PEO89 and unmodified PBd120PEO89 increase when the percentage of carboxylate 
PBd120PEO89 is increased, while the average vesicle size decreases. They are consistent 
with the observation that the carboxylic acid presence disrupts the vesicle formation 
process, hence not being able to be incorporated into an unmodified block copolymer 
membrane at concentrations higher than 80% are reached.  
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CHAPTER III 
 
COVALENT COUPLING OF PRIMARY AMINE TO CARBOXYLATE  
PBd120-PEO89 DIBLOCK COPOLYMER 
 
3.1 Overview 
 Three different primary amines were linked to the carboxylate derivative of the 
diblock copolymer polybutadiene-b-poly(ethylene oxide) (PBd120PEO89, MW 10400 
g/mol), (2), by developing an amination reaction that was carried out in an organic 
solvent. This straightforward reaction successfully formed a covalent bond (peptide 
linkage) between the carboxylic acid and the amines giving products (3), (4) and (5) (see 
Figure 3.3).  The location of the primary amine was determined, hence, it was 
corroborated that these amine are located at the vesicles surface. These functionalized 
derivatives were effectively incorporated into vesicles‟ bilayer and surface density 
control was achieved. 
 
3.2 Introduction 
 Chemical labeling and surface modification of diblock copolymer vesicles are of 
interest due to their potential use as drug delivery systems or mimics of living cells. 
EDC/NHS covalent coupling reaction [90-92] has been widely used to prepare amine-
reactive esters of carboxylate groups. Carboxylate groups (R-COOH) react with EDC (1-
Ethyl-3-[3-dimethylaminopropyl] carbodiimide hydrochloride) to form an amine 
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reactive O-acylisourea intermediate. In the presence of NHS (N-Hydroxysuccinimide) 
this intermediate can be stabilized being converted into an amine-reactive NHS ester 
and, if a primary amine is present (R‟-NH2), the semi-stable NHS ester will react with it 
to form a stable amide bond (R-CONH-R‟) [93-95]. This linking chemistry is commonly 
used in protein and cell studies and it is usually performed in an aqueous environment 
for that reason. 
 
                                
H2N-R 
 
  
Figure 3.1 Covalent coupling reaction of primary amine to carboxylate PBd120PEO89 diblock 
copolymer. The respective functionalized diblock copolymer is produced after a primary amine 
(R = 6AF, COU or NA) is linked to its carboxylate form. 
 
 However, due to the amphiphilic nature of the diblock copolymers used in this 
research, a different approach was necessary and an organic environment was chosen to 
perform this reaction. A number of organic solvents were evaluated, including methanol, 
ethanol, dichloromethane, tetrahydrofuran, toluene as well as mixtures of them but, a 1:1 
mixture of methanol:chloroform (MeOH:CHCl3) was the one that gave the best results. 
This adaptation will allow the diblock copolymer and other reactants to dissolve 
completely to form a homogeneous reaction mixture. 
After synthesizing product (2) as described in Chapter II, a subsequent amination 
reaction was conducted in the organic phase (1:1 MeOH:CHCl3). The free terminal 
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hydroxyl group of the carboxylated PBd120PEO89 diblock copolymer was covalently 
linked to a primary amine through the EDC/NHS coupling. Figure 3.1 shows the general 
structure of the obtained functionalized block polymer (PBd120PEO89-R). The following 
functionalized block copolymers were obtained: PBd120PEO89-6AF, PBd120PEO89-COU 
and PBd120PEO89-NA. The chemical structures of the three different primary amines 
used: 6-amino-fluorescein (6AF), 7-amino-4-(trifluoromethyl) coumarin (COU) and the 
hormone DL-Noradrenaline hydrochloride (NA) are shown in Figure 3.2. 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Structure of the three different primary amines used for the functionalization of 
carboxylate PBd120PEO89 diblock copolymer. From left to right: 6-amino-fluorescein (6AF), 7-
amino-4-(trifluoromethyl) coumarin (COU) and DL-Noradrenaline (NA). 
 
  The covalent coupling was conducted at room temperature using the organic 
solvent, under an inert gas atmosphere to prevent degradation of susceptible reactants 
and under constant agitation. Figure 3.3 describes the synthetic pathway followed to 
produce three functionalized diblock copolymers. The carbodiimide EDC, NHS and the 
carboxylate diblock copolymer were first mixed in the organic solvent for 15 minutes 
prior to the addition of the primary amine. Then, the primary amine of interest was 
 
          
 
          
 
 
6AF NA COU 
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added to the reaction vessel under constant stirring at 900 rpm and reacted for 2 hours. 
The amine-reactive NHS ester (stable intermediate) reacted with the amine and formed a 
stable amide bond. Multiple additions of EDC/NHS (2 hours apart) were performed to 
increase the final product yield and the reaction was run overnight for 24 hours. 
After achieving the synthesis of the fluorophore (6AF and COU) and hormone 
(NA) functionalized diblock copolymers, they were successfully incorporated into 
vesicle‟s bilayer of unreacted PBd120PEO89 at a 1:9 ratio. The fluorescently labeled 
polymers were studied using fluorescent microscopy which led to confirm the efficacy 
of the linking chemistry proposed. Fluorescent spectroscopy helped to elucidate that the 
fluorophore molecule was actually located at the surface of the vesicle bilayer instead of 
any other possible sites such as the hydrophobic bilayer region or just dissolved in 
solution. The two fluorescently label diblock copolymers were also combined in the 
same vesicle structure. The concentration of each labeled polymer can be changed and it 
was shown that surface density can be controlled. 
The hormone labeled polymer (PBd120PEO89-NA) was characterized by UV-Vis 
spectroscopy and used with cultured cells to verify an intracellular response to the drug 
molecule transported to the surface of the functionalized vesicle later on (see Chapter 
IV). 
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Figure 3.3 Synthetic pathway for functionalized diblock copolymers: (3) PBd120PEO89-6AF, 
after amination reaction with 6AF; (4) PBd120PEO89-COU, after amination reaction with COU; 
(5) PBd120PEO89-NA, after amination reaction with NA. Products were obtained by EDC/NHS 
covalent coupling of carboxylate PBd120PEO89 diblock to the respective primary amine.  
 
3.3 Materials 
PBd120PEO89 (MW 10400 g/mol) diblock copolymer and sucrose (ACS reagent) 
(C12H22O11, MW 342.3 g/mol) were purchased from Polymer Source Inc. (Canada) and 
EDC/NHS 
RT, 24 h 
(3) 
(4) 
(5) 
EDC/NHS 
RT, 24 h 
/  
, 24 h 
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Fisher Scientific (Pittsburgh, PA), respectively. Dichloromethane (anhydrous, 99.9%) 
(CH2Cl2, MW 84.93 g/mol), chloroform (99.8+% for analysis ACS, stabilized with 
ethanol) (CHCl3, MW 119.38 g/mol) and methanol (99.8+% for analysis ACS) (MeOH, 
MW 32.04 g/mol) were purchased from Acros Organics (Morris Plains, NJ). 7-amino-4-
(trifluoromethyl) coumarin (COU, MW 229.16 g/mol) and tetrahydrofuran (≥ 99.0% 
ACS reagent) (THF, MW 72.11 g/mol) were purchased from Sigma-Aldrich (St. Louis, 
MO). 6-amino-fluorescein (6AF, MW 347.32 g/mol) and DL-Noradrenaline 
hydrochloride (NA, MW 205.64 g/mol) were purchased from Fluka (Switzerland). 1-
Ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC, MW 191.70) and 
N-Hydroxysuccinimide (NHS, MW 115.09 g/mol) were purchased from Pierce 
(Rockford, IL). Regenerated cellulose dialysis tubing kit (MWCO 8000 g/mol) was 
purchased from Spectra/Por®Biotech and, the previously synthesized carboxylate 
PBd120-PEO89 diblock copolymer. 
 
3.4 Experimental Methods 
Diblock Copolymer Characterization 
IR Spectroscopy. IR spectra of neat liquids were performed using a Bruker FT-IR 
TENSOR™ spectrometer (Billerica, MA) equipped with OPUS™ measurement software. 
Potassium bromide salt plates (McCarthy Scientific Co., Fallbrook, CA) and CH2Cl2, or 
CHCl3, were used to evaluate the polymer samples. 
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UV-Vis Absorbance Measurements. Absorbance measurements of the obtained 
PEO89-PBd120-NA were performed using a Shimadzu UV-Mini 1240 spectrophotometer 
(Columbia, MD). Quartz cuvettes (1 cm pathlenght) and CHCl3 were used as sample 
holder and solvent respectively. Free PEO89-PBd120-NA dissolved in CHCl3 and the 
respective sets of controls were also analyzed by UV-Vis Spectroscopy. 
 
Vesicle Solution Characterization 
Cross-Polarizing Fluorescent Microscopy. Vesicle solutions were imaged using 
the temporary closed sample chamber described before. Phase contrast images of 
polymersomes were taken by a Carl Zeiss Axiovert 200M inverted microscope with 100 
W HBO Mercury vapor lamp coupled to a Zeiss AxioCam MRm camera and a 20X 
objective (numerical aperture of 0.5). Fluorescent microscope images were obtained 
using a FITC band-pass filter with an excitation wavelength of 475 nm (bandwidth of 40 
nm) and an emission wavelength of 530 nm (bandwidth of 50 nm); or a DAPI low-pass 
filter with an excitation wavelength of 365 nm, and an  emission wavelength of 445 nm 
(bandwidth of 50 nm). Vesicle solutions of controls and samples containing 10% w/w of 
PEO89PBd120-6AF or, PEO89PBd120-COU, and 90% of unmodified PEO89PBd120 were 
prepared and imaged under fluorescence microscopy. To facilitate comparison of 
samples to controls, all images were taken sequentially using the same instrumental 
parameters and the recorded images were processed and analyzed identically with the 
program ImageJ. 
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Confocal Microscopy. Confocal images of vesicles containing PEO89-PBd120-
6AF were recorded using a Leica TCS SP5 broad band confocal microscope 
(Bannockburn, IL). Pictures were taken at a scan rate of 400 Hz using a 63X oil 
objective. A 488 nm excitation laser and a 500-600 nm opening emission were used as 
well as a 700V photo multiplier tube power and a 100μm pinhole. 
Fluorescence Spectroscopy. Steady-state excitation and emission spectra were 
recorded on a Photon Technology International (PTI) (Birmingham, NJ) 
QuantaMaster™ UV VIS spectrofluorometer equipped with FeliX32™ software 
package. During vesicle sample measurements, one polarizer was placed before the 
sample and the analyzer placed before the emission collection compartment was rotated 
to a perpendicular angle with respect to the excitation polarizer to reduce intense 
scattering from the polydisperse vesicle sample.  This configuration allows the 
fluorescence of the vesicle system to be recorded. 
In order to determine the location of fluorophore molecules in a vesicle solution 
different environments were simulated by dissolving COU in different solvents: (A) 
aqueous 0.15M PBS solution and the respective excitation and emission spectra were 
recorded at 375 and 490 nm; (B) decane and the excitation and emission spectra were 
recorded at 350 and 400 nm respectively; (C) aqueous 15% w/w PEO (MW 2000 g/mol) 
solution and the excitation and emission spectra were recorded at 385 and 490 nm 
respectively, and finally (D) a vesicle solution containing 10% PBd120PEO89-COU is 
prepared in an aqueous 0.3M sucrose media and the same excitation and emission 
wavelengths used for case (A) were  applied here. 
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3.5 Synthesis of Functionalized Diblock Copolymer 
The reactions were conducted under an argon atmosphere and stirred at 900 rpm 
using a Teflon-covered stir bar. A 5 mL reaction flask was charged with 1 mL of 1:1 
MeOH:CHCl3 solution of 1x10-3 mmol carboxylate PBd120PEO89, 10x10-3 mmol of EDC 
(dissolved in CHCl3) and 5x10-3 mmol of NHS (dissolved in THF). The mixture was 
allowed to react for 15 minutes at room temperature. A primary amine (6AF, COU or 
NA) in a 5 fold excess was dissolved in 1:1 MeOH:CHCl3, added to the reaction flask 
and allowed it to react for 2 hours under constant magnetic stirring. Extra doses of EDC 
and NHS were added every two hours to increase amount of amine linked to carboxylate 
groups. After the cleaning procedure, the final product was dried out in a vacuum oven 
redisolved in CH2Cl2 and an aliquot of the reaction solution was evaporated on a NaCl 
plate and respective the IR spectrum was obtained. 
 
Synthesis of Diblock Copolymer Controls 
The modified diblock copolymers used in controls and samples were prepared 
using different components and were labeled as follow: Control 1: When PBd120PEO89, 
EDC, NHS and a primary amine (6AF, COU or NA) were combined; control 2: when 
carboxylate PBd120PEO89 and a primary amine (6AF, COU or NA) were combined; 
sample: when carboxylate PBd120PEO89, EDC, NHS and a primary amine (6AF, COU or 
NA) were combined. 
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Synthesis of (3) 
Carboxylate PBd120PEO89 (30.40 mg, 2.92x10-3 mmol), EDC (5.60 mg, 
29.23x10-3 mmol), NHS (1.68 mg, 14.62 x10-3 mmol) and 6AF (5.08 mg, 14.62x10-3 
mmol) were reacted in methanol/chloroform as described above. In this manner, product 
3 (24.62 mg, 81% yield) was obtained. IR (ν): 1703 (C=O) cm-1, 1539 (N-H bend) cm-1. 
 
Synthesis of (4) 
Carboxylate PBd120PEO89 (30.40 mg, 2.92x10-3 mmol), EDC (5.60 mg, 
29.23x10-3 mmol), NHS (1.68 mg, 14.62 x10-3 mmol) and COU (3.35 mg, 14.62x10-3 
mmol) were reacted in methanol/chloroform as described above. In this manner, product 
4 (23.41 mg, 77% yield) was obtained. IR (ν): 1703 (C=O) cm-1, 1558 (N-H bend) cm-1. 
 
Synthesis of (5) 
Carboxylate PBd120PEO89 (30.40 mg, 2.92x10-3 mmol), EDC (5.60 mg, 
29.23x10-3 mmol), NHS (1.68 mg, 14.62 x10-3 mmol) and NA (3.01 mg, 14.62x10-3 
mmol) were reacted in methanol/chloroform as described above. In this manner, product 
5 (21.89 mg, 72% yield) was obtained. IR (ν): 1700 (C=O) cm-1, 1538 (N-H bend) cm-1. 
 
 
Functionalized Diblock Copolymer Cleaning Procedure 
The desired product, was redisolved in 2 mL of a 1:1 MeOH:CHCl3 solution and 
cleaned using regenerated cellulose dialysis tubing (MWCO 8000 g/mol). The sample 
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was dialyzed for 2 hours at room temperature against 600 mL (300 times the volume of 
the sample) of 1:1 MeOH:CHCl3 solution, the dialysis buffer was changed and the 
sample dialyzed for another 2 hours. Finally, the dialysis buffer was changed for the 
second time and the sample dialyzed overnight. 
 
3.6 Vesicle Solution Preparation 
A polymer film containing 100 μg of the desired block copolymer or block 
copolymer mixture was formed by evaporation (8 hours) at the bottom of a 5 mL glass 
scintillation vial. Polymersomes were formed by rehydration of this polymer film during 
24 hours at 60ºC with 2 mL of 300 mOsm/kg sucrose solution. In the case of vesicles 
formed with a mixture of block copolymers, X% w/w of functionalized PBd120PEO89 
block copolymer was ideally mixed with Y% w/w of unmodified PBd120PEO89 block 
copolymer before the polymer film formation step. Vesicle solutions of the following 
mixture compositions were formed: 10% w/w of PBd120PEO89-6AF and 90% w/w of 
unmodified PBd120PEO89, 10% w/w of PBd120PEO89-COU and 90% w/w of unmodified 
PBd120PEO89 and, 10% w/w of PBd120PEO89-NA and 90% w/w of unmodified 
PBd120PEO89. The final block copolymer concentration in a vesicle solution of 2 mL is 
4.8 μM. 
Similarly, vesicle solutions of the following mixture compositions (also using a 
300 mOsm/kg sucrose solution) were prepared for surface density control experiments: 
2.5% w/w of PBd120PEO89-COU and 90% w/w of unmodified PBd120PEO89, 5.0% w/w 
of PBd120PEO89-6AF, 5.0% w/w of PBd120PEO89-COU and 90% w/w of unmodified 
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PBd120PEO89 and, 2.5% w/w of PBd120PEO89-6AF, 7.5% w/w of PBd120PEO89-COU and 
90% w/w of unmodified PBd120PEO89. 
 
Vesicle Solution for Fluorescence Spectroscopy 
The vesicle solution used for fluorescence measurements was prepared using a 
300 mOsm/kg sucrose solution, 10% w/w of PBd120PEO89-COU and 90% w/w of 
unmodified PBd120PEO89. 
 
Vesicle Solution Controls 
Vesicle solutions of controls and samples were prepared by combining in a 9:1 
ratio the unreacted PBd120PEO89 and the functionalized diblock copolymer. 
 
3.7 Results and Discussion 
Synthesis of (3)-(5) 
 The EDC/NHS amination reactions effectively produced compounds (3), 
(4) and (5) and yields ≥ 70% were obtained in all cases.  
 
 
Verification of Product (3)-(5) Composition 
 Figure 3.4 compares the spectrum of the unmodified PBd120PEO89 to that of 
PEO89PBd120-6AF, PEO89PBd120-COU and PEO89PBd120-NA. The presence of a 
carbonyl stretch peaks (1730 cm-1) and N-H bend peaks (1540 cm-1) in each IR spectra 
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demonstrates the formation of a secondary amide linkage between the carboxylate 
PBd120PEO89 and the respective primary amine. 
 
Imaging of 6AF Functionalized Vesicles 
Figure 3.5 shows a set of images of polymersomes made up with 90% 
PBd120PEO89 and 10% PBd120PEO89-6AF following a standard vesicle formation 
procedure in a 310 mOsm/kg sucrose solution. Figure 3.5(A) shows a phase contrast 
microscopy image of a well defined vesicle and Figure 3.5(B) shows the same vesicle is 
observed under fluorescent light (FITC filter) where, the fluorescent vesicle membrane 
can be clearly seen as a bright ring after focusing in its middle plane. The confocal 
image shown in Figure 3.5(C) is a side view of a fluorescent vesicle sitting over a cover 
glass and it is evident that the fluidity of the polymer membrane is preserved. These 
images corroborate that the carboxylate PBd120PEO89 reacted with 6AF (fluorescent) to 
form the corresponding amide (PBd120PEO89-6AF) and that modified block copolymers 
were successfully incorporated into the vesicles without disrupting its original 
morphology and characteristics such as membrane fluidity. 
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Figure 3.4 Comparison between the IR spectra of the unmodified PBd120PEO89 and the covalent 
coupling reaction products from the respective carboxylate block copolymer, 6-amino-
fluorescein PBd120PEO89 (PBd120PEO89-6AF), 7-amino-4-(trifluoromethyl) coumarin PBd120-
PEO89 (PBd120PEO89-COU) and  DL-Noradrenaline PBd120PEO89 (PBd120PEO89-NA). Overlay of 
IR spectra showing:  (A) PBd120PEO89 (top) and PBd120PEO89-6AF product. (B) PBd120PEO89 
and PBd120PEO89-COU product. (C) PBd120PEO89 and PBd120PEO89-NA product. The presence 
of a carbonyl stretch (around 1700 cm-1) and a peak corresponding to a N-H bend (around 1530 
cm-1) indicates the formation of an amide bond between the block copolymer and the primary 
amines. 
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Figure 3.5 Block copolymer vesicles of 10% PBd120PEO89-6AF and 90% PBd120PEO89. (A) 
Phase contrast image. (B) Fluorescent image taken using FITC filter. (C) Side view image 
obtained by confocal microscopy. 
 
Fluorescent Microscopy Analysis of Functionalized Vesicles 
 Figure 3.6 and Figure 3.7 demonstrate through a set of controls and samples the 
effectiveness of the covalent coupling reaction of primary amines to the carboxylate end 
groups of carboxylate PBd120PEO89. For 6AF, phase contrast images of three types of 
vesicles (control 1, control 2 and sample) are shown in Figure 3.6(A) while the 
respective fluorescent images, taken using a FITC filter, can be observed in Figure 
3.6(B). All the images were recorded consecutively and analyzed using the same 
microscope settings in order to minimize effects due to fluorescent lamp intensity or 
image processing. Table 3.1 shows the peak and average values of the vesicle‟s intensity 
profiles of controls and samples for the 6AF case. Three different vesicle sets were 
analyzed and in each case peak 1 and 2 correspond to both sides of the vesicle‟s bilayer 
observed on the transversal cut images obtained through fluorescent microscopy. 
Similarly, Table 3.2 shows the peak and average values of the vesicle‟s intensity profiles 
of controls and samples for the COU case. 
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Table 3.1 Intensity profile values of controls and samples of PBd120PEO89-6AF functionalized 
vesicles. 
 
 Control 1 (Intensity units) Control 2  (Intensity units) Sample  (Intensity units) 
 
Peak 1 Peak 2 Average Peak 1 Peak 2 Average Peak 1 Peak 2 Average 
 
Trial 1 6.9 6.3 6.6 45.9 46.0 45.9 118.6 132.0 125.3 
Trial 2 8.3 9.3 8.8 77.5 75.5 76.5 184.7 210.8 197.8 
Trial 3 8.2 7.1 7.6 71.1 68.8 69.9 137.7 172.8 155.3 
StDev   1.1   16.1   36.4 
  
Table 3.2 Intensity profile values of controls and samples of PBd120PEO89-COU functionalized 
vesicles. 
 
 Control 1 (Intensity units) Control 2  (Intensity units) Sample  (Intensity units) 
 
Peak 1 Peak 2 Average Peak 1 Peak 2 Average Peak 1 Peak 2 Average 
 
Trial 1 23.9 16.0 19.9 50.8 50.5 50.6 310.8 314.8 312.8 
Trial 2 26.0 24.0 25.0 47.0 46.0 46.5 306.0 302.0 304.0 
Trial 3 13.6 11.0 12.3 34.7 32.9 33.8 186.7 191.0 188.9 
StDev   6.4   8.8   69.1 
 
Control 1 lacks a carboxyl group at the end of the block copolymer chain. In the 
case of control 2, amide bonds could form due to the presence of a free primary amine 
(6AF) and the carboxylate PBd120PEO89. It can clearly be observed that the sample 
exhibits higher fluorescence intensity than both controls which indicates a higher percent 
of conversion for the coupling reaction product (PBd120PEO89-6AF). Figure 3.6(C) 
confirms the differences in fluorescent intensities for the two controls and the sample. 
In the COU case, the same types of block copolymer vesicles were prepared 
(control 1, control 2 and sample) and fluorescent images were recorder using a DAPI 
filter. Comparable results to the 6AF case are obtained and shown in Figure 3.7. Since 
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there is no carboxyl group present in control 1, and the slight fluorescence of control 2 
suggests the formation of only few amide bonds, the higher fluorescence intensity 
exhibited by the sample indicates a higher percent conversion for the coupling reaction 
between the carboxylate PBd120PEO89 and COU. 
 
 
 
Figure 3.6 Images of fluorescent block copolymer vesicles from PBd120PEO89 and PBd120PEO89-
6AF mixed at 9:1 ratio. The table above explains the reactants used for controls and the sample. 
(A) Phase contrast images. (B) Fluorescent images taken using FITC filter. (C) Intensity profiles 
corresponding to each fluorescent vesicle shown in (B). 
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Figure 3.7 Images of fluorescent block copolymer vesicles from PBd120PEO89 and PBd120PEO89-
COU mixed at 9:1 ratio. The table above explains the reactants used for controls and the sample. 
(A) Phase contrast images. (B) Fluorescent images taken using DAPI filter. (C) Intensity profiles 
corresponding to each fluorescent vesicle shown in (B). 
 
UV-Vis Spectroscopy Analysis of Hormone Functionalized Diblock Copolymer 
Figure 3.8 shows the concentration of PBd120PEO89-NA present in control 1, 
control 2 and sample determined by UV absorbance measurements of the respective free 
polymer dissolved in CHCl3. 
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Figure 3.8 UV absorbance of block copolymer PBd120PEO89-NA in CHCl3 taken at λ=380 nm. 
Control 1 has no modified polymer. Control 2 has no coupling reagents. Sample shows the final 
product (73% conversion). Polymer concentrations are 1.9 mM. 
  
 A 1.9 mM carboxylate PBd120PEO89 solution is used for these amination 
reactions and the PBd120PEO89-NA yields obtained for control 1, control 2 and sample 
by UV absorbance measurements are 22, 53, and 73% respectively. Due to the lack of a 
carboxyl group in the block copolymer chain of control 1 no further reaction can occur 
however, amide bonds can be formed in control 2 due to the presence of a primary amine 
(NA) and the carboxylate PBd120PEO89. Lastly, the higher fluorescence exhibited by the 
sample indicates again a higher percent of conversion for the linking reaction between 
the carboxylate PBd120PEO89 and NA. 
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Fluorophore Localization Through Fluorescence Spectroscopy 
 In order to establish the actual location of the fluorescent primary amines used 
(6AF and COU) during the EDC/NHS coupling to the carboxylate PBd120PEO89, 
fluorescence measurements were conducted (Figure 3.9). The three possible locations 
where the fluorophores can be found are: (A) Free in aqueous solution, where no 
covalent coupling with the carboxylate PBd120PEO89 was achieved. (B) Free and 
solubilized in the hydrophobic region of the vesicle membrane, when no reaction has 
occurred and the free fluorophore is partially solubilized in the vesicle membrane. (C) 
Covalently attached to the carboxylate PBd120PEO89. With the aim of simulating these 
environments, COU was dissolved in three different solutions as described in the 
experimental section and compared to a vesicle solution containing 10% PBd120PEO89-
COU. 
 Figures 3.9 (A-C) shows the resultant fluorescence spectra of these simulated 
environments while Figure 3.9(D) shows the fluorescence spectra of a vesicle solution 
formed with the functionalized PBd120PEO89-COU. The vesicle solution spectra (Figure 
3.9(D)) does not match the results presented in Figures 3.9(A) or 3.9(B) while Figure 
3.9(C) shows very similar emission and absorption peaks. These results indicate that the 
fluorophore is not in the hydrophobic region or free in solution, but associated with the 
PEO block of the polymer. 
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Figure 3.9 Fluorescent measurements of dissolved COU in different media simulating various 
environments (A) COU dissolved in an aqueous 0.15 M PBS solution. Excitation (375 nm) and 
emission (490 nm) were used respectively. (B) COU dissolved in decane. Excitation (350 nm) 
and emission (400 nm). (C) COU dissolved in an aqueous 15% w/w PEO (MW ~2000) solution. 
Excitation (385 nm) and emission (490 nm). (D) Vesicle solution of 10% PBd120PEO89-COU in 
an aqueous 0.3 M sucrose solution. Same excitation and emission wavelength used as in (A). 
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Surface Density Control of Functionalized PBd120PEO89-6AF and PBd120PEO89-
COU in Diblock Copolymer Vesicles  
 Figure 3.10 shows the results of a surface density experiment were the amount 
and type of fluorescent PBd120PEO89, either linked to 6AF or COU, were controlled and 
deliberately modified. Block copolymer vesicles were formed using 90% PBd120PEO89 
and 10% of a mixture of PBd120PEO89-6AF and PBd120PEO89-COU, ranging from a 
minimum of 2.5% to a maximum of 7.5% of each component. 
 These fluorescent microscope images were taken using separate FITC/DAPI 
filters. Each column represents one set of images of the same vesicle. Rows 1 and 2 
show images taken with DAPI (to detect COU presence) and FITC (to detect 6AF 
presence) filter respectively and, while row 1 shows an increase in the PBd120PEO89-
COU concentration from left to right (2.5%, 5.0% and 7.5% respectively), row 2 shows 
an increase in the PBd120PEO89-6AF concentration from right to left (2.5%, 5.0% and 
7.5% respectively). Row 3 illustrates the superposition of the two previous images in the 
same column (actual image seen through the eye piece or microscope camera).  
 Images shown in column 1 correspond to a block copolymer vesicle made up 
with 7.5% PBd120PEO89-COU (Figure 3.10(A)) and 2.5% PBd120PEO89-6AF (Figure 
3.10(D)). Column 2 present the images of a vesicle made up with 5.0% PBd120PEO89-
COU (Figure 3.10(B)) and 5.0% PBd120PEO89-6AF (Figure 3.10(E)). Finally, column 3 
displays the images of a vesicle made up with 2.5% PBd120PEO89-COU (Figure 3.10(C)) 
and 7.5% PBd120PEO89-6AF (Figure 3.10(F)). 
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Figure 3.10 Surface density control of fluorescent block copolymer in polymersomes. 90% 
PBd120PEO89 and 10% of a mixture of PBd120PEO89-COU (A-C) and PBd120PEO89-6AF (D-F), 
ranging from a minimum of 2.5% to a maximum of 7.5% of each component. The combined or 
total fluorescence is shown in figures G-I. The amount and type of fluorescent PBd120PEO89 were 
tailored enabling us to exert surface density control of the vesicle components. 
  
 Figures 3.10(G-I) show the overlay of the respective upper images were the total 
fluorescence is constant while the blue and green vary with concentration. The overlay 
images of the COU and 6AF channels show the total fluorescence intensity of the three 
types of vesicles formed and demonstrate that the amount and type of functionalized 
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block copolymer incorporated into the vesicle can be tailored and that the surface density 
of a polymer vesicle can be accurately controlled. 
 
3.8 Conclusions 
 Different primary amines were covalently attached to the previously synthesized 
carboxylate block copolymer through a modified amination reaction performed in 
organic phase. The peptide bond formation was confirmed through FT-IR spectroscopy 
and fluorescent microscopy. This constitutes a singular synthetic approach of this widely 
used coupling reaction due to the amphiphilic nature of the diblock copolymers that 
enable us to apply it to other molecule types. 
 Polymersomes containing 90% of the unmodified block copolymer and 10% of 
one of the modified block copolymers (PBd120PEO89-6AF, PBd120PEO89-COU, and 
PBd120PEO89-NA) were prepared and the effective incorporation of the latest one was 
demonstrated through fluorescence microscopy and UV absorbance measurements. Two 
types of modified diblock copolymers (PBd120PEO89-6AF, PBd120PEO89-COU) were 
also properly integrated into the same vesicle and, surface density control of the two 
fluorophores was achieved and confirmed through fluorescence microscopy. 
 This type of synthesis opens the possibility to produce different functionalized 
diblocks, with diverse uses and applications, which can be incorporated into the 
polymersome bilayer with the aim of safe transportation and further targeted delivery of 
the desired molecule. 
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CHAPTER IV 
 
CELL RESPONSE TO HORMONE FUNCTIONALIZED  
PBd120PEO89 DIBLOCK COPOLYMER  VESICLES
 
4.1 Overview 
 After the successful synthesis of functionalized diblock copolymers that can be 
integrated into polymeric vesicles, as described in previous chapters shows that 
functionalized vesicles can interact with living cells to induce a cell response [96]. A 
series of control and samples were evaluated and compared. A functionalized vesicle 
with noradrenaline (NA) molecules attached to its surface was placed in close contact 
with a cell surface using micropipette aspiration technique. We observed that the 
delivered hormone was bound to the noradrenaline a-receptors located on the surface of 
smooth muscle cells (SMC) and produced the expected cell response confirmed by as an 
increase of fluorescence using fluorescent microscopy. 
 
4.2 Introduction 
Noradrenaline (NA), also called norepinephrine, is one of the principal hormones 
and neurotransmitters of the nervous system. The noradrenaline effects includes the 
activation of the sympathetic nervous system, which causes the raise of glucose 
concentration in blood, increase in blood pressure and heartbeat rate, and boost muscular 
power and resistance to fatigue [87, 97]. It may also cause exocytosis, adhesion of cells 
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to the extracellular matrix, dilation of pupils and dilation of air passages in the lungs, 
narrowing of blood vessels in non-essential organs, and even apoptosis. 
Noradrenaline is produced by the adrenal gland located on top of the kidneys and 
stored in small vesicles. In the occurrence of an impulse at a nerve terminal, the 
noradrenaline containing vesicles are released. After noradrenaline is used, the residual 
NA molecules are oxidized to inactive material or restored for later use. Noradrenaline 
interacts with two types of cell membrane receptors, named „a‟ and „b‟. The b-receptors 
cause relaxation, whereas the a-receptors cause contraction of smooth muscle cells when 
activated. The interaction between noradrenaline and the cell surface receptors [97-99] 
occurs via a cascade reaction involving a number of secondary messengers that amplify 
the strength of the transmitted signal. 
Due to the importance of well balanced presence of molecules of this hormone in 
human body, we developed here diblock copolymer vesicles capable of carrying 
noradrenaline molecules in their surfaces. These functionalize vesicles can bind to a-
receptors of smooth muscle cells to restore blood pressure to normal in life threatening 
situations when it has dropped dangerously low (known as acute hypotension). 
Currently, noradrenaline is administered in solution through injection. But, the outflow 
of it from veins can cause death of the tissue around therein. Hence, a controlled 
distribution of the drug using functionalized vesicles may be an alternative medical 
treatment. 
In company to smooth muscle cell contractions, there is a rise in serum calcium 
[22, 37] that enables us to monitor the cell response to the presence of noradrenaline. 
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Here, we chose to observe and image via fluorescent microscopy the intracellular 
increase of Ca2+ ions through their coupling to a fluorescent indicator, such as Fluo-4 
AM [100-102]. The increase in fluorescence intensity was caused by a series of controls 
and samples placed in closed contact with rat aortic smooth muscle cell cultures. The 
Fluo-4 AM ester is an uncharged molecule that is permeable to cell membranes. Once 
inside the cell, it binds to Ca2+ ions, and can be imaged due to the strong fluorescence 
intensity produced when excited at 488 nm [43, 98]. 
 
4.3 Materials 
Previously synthesized noradrenaline Poly(butadiene-b-ethylene oxide) (PBd120-
PEO89-NA) block copolymer and rat aortic smooth muscle cells (RASMC). Sucrose 
(ACS reagent) (C12H22O11, MW 342.3 g/mol) and DL-Noradrenaline hydrochloride 
(NA, MW 205.64 g/mol) were purchased from Fisher Scientific (Pittsburgh, PA) and 
Fluka (Switzerland), respectively. PBd120-PEO89 and Poly(butadiene-b-ethylene oxide) 
(PBd33PEO20, MW 2700 g/mol) block copolymers were purchased from Polymer Source 
Inc. (Canada). Carboxylate-modified polystyrene microspheres (red fluorescent, 2 μm in 
diameter) were purchased from Molecular Probes™, Invitrogen (Carlsbad, CA). High 
quality dimethylsulfoxyde (DMSO) ((CH3)2SO, MW 78.13 g.mol) and Pluronic® F-127 
were purchased from Sigma-Aldrich (St. Louis, MO).  Dulbecco‟s Modified Eagle‟s 
Medium (DMEM) (4.5 g/L glucose, L-glutamine, sodium pyruvate) and Antibiotic-
Antimycotic solution (10000 I.U./mL penicillin, 10000 μg/mL streptomycin, 25 μg/mL 
amphotericin B) were purchased from Cellgro®, Mediatech, Inc. (Herndon, VA). 
 59 
Phosphate buffered saline 1X (PBS) and Bovine Calf Serum (BCS) were purchased from 
HyClone, Thermo Fisher Scientific, Inc. Fluo4 AM was purchased from Invitrogen 
(Carlsbad, CA). 
 
4.4 Experimental Methods 
Vesicle and Cell Characterization 
Micropipette Aspiration. A single vesicle was hold close to a cultured cell using 
a micropipette aspirator. In this technique, vesicles were aspirated into a pipette of small 
inner diameter (approximate 8 µm) by applying suction pressure causing changes of the 
vesicle‟s membrane tension. This highly specialized technique required custom 
laboratory fabrication of glass micropipettes by a micropipette puller and a micro forge 
equipped with a microscope.  
 
Microscope Imaging and Cross-Polarizing Fluorescent Microscopy. Cells and 
vesicles were imaged using an open Petri dish and a silicone rubber well as a vesicle 
chamber. Individual vesicles were hold using micropipette aspiration technique to place 
them in close contact with cell surface. Bright field images were taken via a 20X 
objective of a Carl Zeiss Axiovert 200M inverted microscope with 100 W HBO Mercury 
vapor lamp and recorded by a Zeiss AxioCam MRm camera. Fluorescent microscope 
images were obtained using a FITC band-pass filter with an excitation wavelength of 
475 nm (bandwidth of 40 nm) and an emission wavelength of 530 nm (bandwidth of 50 
nm). All images were recorded consecutively using the same microscope settings in 
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order to minimize effects due to fluorescent lamp intensity fluctuation or image 
processing. The recorded images were processed and analyzed with the program ImageJ. 
In all cases, consecutive fluorescent images (50 to 150 frames) of the same 
RASMC culture region are taken every 2 seconds. In each case, three smaller areas were 
numbered and marked by a square in each image and the fluorescence intensity of the 
cells contained in these areas was as a function of time before and after the addition of 
controls and functionalized beads or vesicles. 
 
Cell Seeding Procedure 
 RASMC were transferred into a 60x15 mm round Petri dish and a final volume 
of 5 mL was reached by adding DMEM. The cells were incubated at 37ºC for 2 days or 
until a confluent cell layer was obtained. The DMEM media was changed every 2 days 
and cells were reseeded every 4-5 days. 
 
Cell Staining Procedure 
 A 2.5 mM Fluo4 AM stock solution was prepared by dissolving 50 μg of Fluo4 
AM in 18 μL of a 20% Pluronic® F-127 solution prepared in DMSO (0.4 g of Pluronic® 
F-127 in 2 mL of DMSO). The stock solution was then diluted to a 2.5 μM Fluo-4 AM 
solution by adding 18 mL of PBS. The Petri dish containing the seeded cells was 
charged with 1 mL of the 2.5 μM Fluo-4 AM solution and exposed to it for 40 minutes at 
room temperature. 
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4.5 Synthesis of Hormone Functionalized Diblock Copolymer 
 The reactions were conducted under an argon atmosphere and stirred using a 
Teflon-covered stir bar. 
 
Hormone Functionalized Polystyrene Microspheres 
A 5 mL reaction flask was charged with 1 mL aqueous solution of the 
carboxylate-modified polystyrene microspheres, 10x10-3 mmol of EDC and 5x10-3 mmol 
of NHS. The reaction mixture was allowed to react for 15 minutes at room temperature 
and under constant magnetic stirring. NA in excess (10x10-3 mmol) was added to the 
reaction flask and allowed it to react for 2 hours. Extra doses of EDC and NHS were 
added every two hours to increase amount of amine linked to carboxylate groups. The 
final clean product was resuspended in 1 mL of DMEM.  
 
Polystyrene Microspheres Control Suspension 
 A control bead solution was prepared at the same time but without addition of 
linking agents. A 5 mL reaction flask was charged with 1 mL aqueous solution of the 
carboxylate-modified polystyrene microspheres and magnetically stirred for 15 minutes 
at room temperature. NA (10x10-3 mmol) was added to the reaction flask and allowed it 
to react for 2 hours. The final clean product was resuspended in 1 mL of DMEM.  
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Functionalized Microspheres Cleaning Procedure 
The reaction mixture was cleaned using microcentrifuge filtration tubes (0.22 μm 
pore size). The functionalized beads were resuspended in 1 mL aqueous solution using a 
vortex and then filtrated. This procedure was repeated 3 times per sample and blanks. 
 
4.6 Vesicle Solution Preparation 
A polymer film containing 100 μg of the desired block copolymer or block 
copolymer mixture was formed by evaporation (8 hours) at the bottom of a 5 mL glass 
scintillation vial. Polymersomes were formed by rehydration of this polymer film during 
24 hours at 60ºC with 2 mL sucrose solution. A 340 mOsm/kg sucrose solution was used 
during the rehydration step because of the higher osmolality of DMEM (350 mOsm/kg). 
A vesicle solution of the following mixture composition was formed: 10% w/w of 
PBd120PEO89-NA and 90% w/w of unmodified PBd33PEO20. The final block copolymer 
concentration in a vesicle solution of 2 mL is 4.8 μM. 
 
Vesicle Solution Controls 
Vesicle solutions of controls and samples are prepared by combining in a 9:1 
ratio the unreacted PBd33PEO20 and the functionalized diblock copolymer control 1 or 
control 2. 
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4.7 Results and Discussion 
 Six cell response experiments were performed and the fluorescence intensity 
increase caused by controls and samples was recorded (see Table 4.1). RASMC were 
directly exposed to: NA dissolved in sucrose solution (free NA); carboxylate-modified 
polystyrene microspheres (control A); carboxylate-modified polystyrene microspheres 
linked to NA (control B); vesicle made with 10% unreacted PBd120PEO89 and 90% 
unreacted PBd33PEO20 (control 1); vesicle made with 10% carboxylate PBd120PEO89 and 
90% unreacted PBd33PEO20 (control 2) and, vesicle made with 10% PBd120PEO89-NA 
and 90% unreacted PBd33PEO20 (sample).  
 
Table 4.1 Reactants used to prepare controls and sample products. In the case of vesicles, they 
were formed using a 9:1 ratio of PBd33PEO20 and functionalized polymer. 
 
Free NA 
Control A 
(Microsphere) 
Control B 
(Microsphere) 
Control 1 
(Vesicle) 
Control 2 
(Vesicle) 
Sample       
(Vesicle) 
NA NA NA NA NA NA 
  EDC EDC  EDC 
  NHS NHS  NHS 
 Microsphere Microsphere 
Unreacted 
PBd120PEO89 
Carboxylate 
PBd120PEO89 
Carboxylate 
PBd120PEO89 
NA Microsphere Microsphere-NA Unreacted PBd120PEO89 
Carboxylate 
PBd120PEO89 
PBd120PEO89-NA 
 
Cell Imaging Results of Free Noradrenaline Control 
Figure 4.1 shows the cell response to the addition of free NA solution to the cell 
media (final NA concentration of 1μM). Figure 4.1(A) shows the RASMC region of 
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study before the addition of free NA and three smaller isolated areas, which were 
analyzed and compared with the results obtained after the addition of free NA. 
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Figure 4.1 Images of RASMC cultures before and after addition of 1μM free NA. (A) Image 
taken using FITC filter before addition of free NA. (B) Image taken using FITC filter after 
addition of free NA. The scale bar represents 50 μm in both images. (C) Intensity profile of 
highlighted areas shown in A. (D) Intensity profile of highlighted areas shown in B.  
 
 Figure 4.1(B) shows the same region after the addition of free NA. Figure 4.1(C) 
shows the intensity profiles of the highlighted areas shown in Figure 4.1(A). During the 
evaluation period, where no NA was added, the fluorescence intensity stays constant 
without any substantial variation. Quite the opposite is shown by the intensity profiles 
presented in Figure 4.1(D) corresponding to Figure 4.1(B). A dramatic increase in the 
cell‟s fluorescence intensity was observed due to the presence of free NA molecules. 
Time (Frames) Time (Frames) 
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These images and profiles corroborate that cells react to the presence of NA and provide 
us with the type of response that should be expected from this cell-drug system. 
 
Cell Imaging Results of Carboxylate-Modified Polystyrene Control Beads 
Figure 4.2 shows the cell response to control beads when added to the cell 
culture. These control beads were exposed to all the reaction steps involved in the 
covalent linking procedure where NA was used as the primary amine but without the 
addition of linking agents. For this control beads, no linking reaction was expected to 
occur and, after the cleaning procedure, microspheres with no modification were 
obtained. Figure 4.2(A) shows the RASMC region of study before the addition of control 
beads with three smaller isolated areas. Figure 4.2(B) shows the same region after the 
addition of control beads. Figure 4.2(C) shows the intensity profiles of the highlighted 
areas shown in Figure 4.2(A) and it can be observed that during the evaluation period, 
where no control beads are added, the fluorescence intensity stay almost constant 
without any substantial variation. Figure 4.2(D) shows the intensity profiles 
corresponding to Figure 4.2(B) and no significant change in the intensity values with 
respect to Figure 4.2(C) is observed meaning that there is no NA present to cause cell 
response. This result support the fact that no NA was linked to the carboxylate beads 
because of the absence of a linking agent. 
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Figure 4.2 Images of RASMC cultures before and after addition of carboxylate-modified 
polystyrene microspheres control. (A) Fluorescent image taken using FITC filter before addition 
of control microspheres. (B)  Fluorescent image taken using FITC filter after addition of control 
microspheres. The scale bar represents 50 μm in both images. (C) Intensity profile of highlighted 
areas shown in A. D. Intensity profile of highlighted areas shown in B.  
 
Cell Imaging Results of Hormone Functionalized Polystyrene Beads 
Figure 4.3 shows the cell response to the addition of NA functionalized 
polystyrene microspheres to the cell culture. These NA functionalized beads are 
obtained as described in the experimental section. Figure 4.3(A) shows the RASMC 
region of study before the addition of functionalized beads with three smaller isolated 
areas. Figure 4.3(B) shows the same region after the addition of functionalized. Figure 
4.3(C) plots the intensity profiles of the highlighted areas shown in Figure 4.3(A) and 
Time (Frames) Time (Frames) 
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similar to the previous control experiment, the fluorescence intensity is kept stable 
during the evaluation time.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 Images of RASMC cultures before and after addition of carboxylate-modified 
polystyrene microspheres covalently linked to NA. (A) Fluorescent image taken using FITC 
filter before addition of microspheres linked to NA. (B)  Fluorescent image taken using FITC 
filter after addition of microspheres linked to NA. The scale bar represents 50 μm in both 
images. (C) Intensity profile of highlighted areas shown in A. (D) Intensity profile of highlighted 
areas shown in B.  
 
 Figure 4.3(D) shows the intensity profiles of Figure 4.3(B) and in this case, there 
is a considerable change in the fluorescence intensity values in contrast to Figure 4.3(C), 
which means that NA is linked to the carboxylate-modified polystyrene beads through 
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the EDC/NHS linking chemistry and that the NA carried by these microspheres 
promotes a cell response. The fluorescence intensity is significantly increased at around 
frames 20 to 30 (40 seconds to 60 seconds) and increase slopes are observed in the 
intensity profiles. The smaller intensity increase experienced in this case is attributed to 
the reduced dose of NA transported by the beads in comparison with the free NA 
experiment. 
 
Cell Imaging Results of Hormone Functionalized Vesicles and Controls 
Figure 4.4 shows two views of a NA functionalized block copolymer vesicle 
being placed in close contact with the cells surface through micropipette aspiration 
technique. In the same manner, control vesicle 1 and 2 (previously described in the 
experimental methods) were evaluated but no significant increase in the cells‟ 
fluorescent intensity was observed. 
Figure 4.4(A) shows a bright field image where the non-fluorescent vesicle is at 
the tip of a glass micropipette after applying a small amount of suction while Figure 
4.4(B) shows a fluorescent image of the same field of view but neither the vesicle nor 
the micropipette can be observed. The functionalized vesicles are placed in a rubber 
chamber that isolate them from the cells until one of them is picked up using a 
micropipette. In this way, any cell response is ensured due to a single vesicle placed in 
contact with the cells. 
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Figure 4.4 Images of a block copolymer vesicle made up with 10% PBd120PEO89-NA being 
placed in close contact with RASMC using micropipette aspiration technique. (A) Bright field 
image taken using contrast microscopy. (B) Fluorescent image taken using FITC filter. The scale 
bar represents 50 μm in both images. 
 
Figure 4.5 shows the cell response when a single NA functionalized block 
copolymer vesicle was placed in contact with the cell‟s surface. The NA functionalized 
vesicles were obtained as described in the experimental methods by using 10% of the 
previously synthesized PBd120PEO89-NA block copolymer and 90% of a much shorter 
diblock copolymer (PBd33PEO20). The use of PBd33PEO20 allowed the NA 
functionalized polymer brushes to be more accessible at the vesicle‟s surface preventing 
them to be buried and entangled in the vesicle‟s bilayer region. Figure 4.5(A) shows the 
RASMC region of study before contact with the functionalized vesicle and three smaller 
isolated areas. Figure 4.5(B) shows the same region after contact with the functionalized 
vesicle.  
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Figure 4.5 Images before and after contact of RASMC culture with a single block copolymer 
vesicle made with unreacted PBd33PEO20 and PBd120PEO89-NA mixed in a 9:1 ratio. (A) 
Fluorescent image taken using FITC filter before putting the cells in contact with a NA 
functionalized block copolymer vesicle. (B)  Fluorescent image taken using FITC filter after 
putting the cells in contact with a NA functionalized block copolymer vesicle. The scale bar 
represents 50 μm in both images. (C) Intensity profile of highlighted areas shown in B. 
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Figure 4.5(C) shows the intensity profiles of the highlighted areas shown in 
Figure 4.5(B) and a significant increase in the fluorescence intensity values around 
frame 60 is observed right after the vesicle made contact with the cell surface. After an 
intensity peak is reached at around frame 75 (150 seconds), the signal decays 
progressively until the end of the experiment. The difference between the intensity 
values reached in each case can be explained by the limited NA molecules available at 
the vesicle‟s surface producing a low dose response. Also, due to the natural 
heterogeneity of cells, variant amount of surface receptors existed and different 
responses can be expected. Signal transmission between exposed and non exposed cells 
was also observed as well as smooth muscle cell contraction in regions far away from 
the original stimulus site. 
 
4.8 Conclusions 
These series of cell experiments provided us with information about the cell 
response expected from the RASCM/NA system. The free NA cell experiments showed 
us what type of cell response was produced when free NA binds to the RASMC surface 
receptors: An abrupt increase in the fluoresce intensity followed by a progressive 
intensity decay. The NA functionalized polystyrene microspheres verified that the 
surface immobilized NA was transported by these beads through simple contact between 
them and the cell surface.  
The use of micropipette aspiration technique provided a different experimental 
setup that allowed us to study, in a controlled manner, the interaction between a single 
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NA functionalized polymeric vesicle and the cell surface.  The intensity profile recorded 
during the functionalized vesicle experiment resembled the one of the free NA profile. 
This profile shape agreement corroborated the hypothesis of NA delivery by the 
functionalized vesicles. These results reconfirm that NA was transported through these 
functionalized vesicles and t produced a cell response. 
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CHAPTER V 
 
REDUCTION-RESPONSIVE FUNCTIONALIZED PBd120PEO89 
DIBLOCK COPOLYMER VESICLES 
 
5.1 Overview 
Due to the increased interest in the high effective of stimuli-responsive drug 
delivery vehicles, we designed and synthesized a functionalized diblock copolymer that 
contains a disulfide linkage, which acts as a potential reducible moiety, and a red 
fluorophore, which simulates a drug molecule. This reduction-responsive diblock 
copolymer was produced through a simple one-pot two-step reaction in organic solvent 
by linking cystamine to 5-TAMRA-succinimidyl (product 6) and then connecting it to 
carboxylate PBd120PEO89 (product 7 or PBd120PEO89-cystamine-5-TAMRA) and finally, 
it was successfully incorporated into a vesicle‟s bilayer. Exposure to tris(2-
carboxyethyl)phosphine hydrochloride (TCEP), which simulates a reductive cytoplasmic 
environment, caused the disulfide bonds to rupture and to release the drug molecule into 
solution. 
 
5.2 Introduction 
 One of the polymersome‟s applications that has caught great attention is its 
possibility as a drug delivery system. Various approaches have been carried out to fulfill 
this aim, and sophisticated designs have been attempted based on the variation and 
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control of different characteristics of the polymersomes‟ building blocks. Hammer et al. 
[63] used of bioresorbable polymeric vesicles of poly(ethylene oxide)-b-
polycaprolactone where the biodegradability of polycaprolactone was expected to cause 
a complete in vivo degradation of the vesicle to release its enclosed drug. Napoli et al. 
[103] suggested the use of ABA block copolymers, where polyethylene glycol was used 
as block A and poly(propylene sulphide), a polymer that contains sulphide moieties, as 
block B. Here, a mechanism of oxidative destabilization of the vesicles was used to 
release the contained drug. Sun et al. [104] demonstrated a reduction-responsive 
biodegradable PEG-SS-PCL micelles and its intracellular drug release capability 
triggered by a reducing environment. It showed the efficacy and advantages such type of 
controlled-release in comparison with the traditional drug delivery approach. 
 Herein, a functionalized block copolymer containing a disulfide moiety was 
synthesized using a similar amination procedure described in Chapter III. First, the 
fluorophore 5-TAMRA-succinimidyl was used as a fluorescent marker and linked to a 
cystamine molecule. No linking agents were required to form the 5-TAMRA-cystamine 
product due to the presence of an N-succinimidyl ester group which greatly enhances the 
coupling efficiency. Subsequently, an EDC/NHS reaction was performed to link 5-
TAMRA-cystamine to the carboxylate PBd120PEO89. The final product was a 
functionalized block copolymer containing the red fluorophore linked to PBd120PEO89 
with a cystamine molecule in between them (5-TAMRA-cystamine-PEO89-PBd120). 
Figure 5.1 shows this two-step synthetic pathway. 
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Figure 5.1 Two-step synthesis of functionalized diblock copolymers by covalent coupling of 
carboxylate PBd120PEO89 diblock copolymer to a cystamine and 5-TAMRA-succinimidyl: (6) 5-
TAMRA-cystamine, after amination reaction between them (7) PBd120PEO89-cystamine-5-
TAMRA, after amination reaction of (6) with carboxylate PBd120PEO89. 
(6) 
(7) 
5-TAMRA-Succinimidyl 
(fluorophore) 
Cystamine 
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Figure 5.2 Schematic representation of the two-step synthesis of functionalized PBd120PEO89-
cystamine-5-TAMRA diblock copolymer and its purpose as a reducible surface element once 
incorporated into a polymersome. (A) Formation of product 7 by covalent coupling of 5-
TAMRA-cystamine (6) to carboxylate PBd120PEO89. (B) Successful incorporation of product 7 
into a polymersome and its further exposure to a reducible environment simulated by the 
presence of TCEP. The change in the polymersome surroundings caused the breakage of 
disulfide bonds present in product 7 and subsequent release of 5-TAMRA into solution.  
Reduction-responsive 
vesicle after TCEP 
Reduction-responsive 
vesicle 
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 Polymersomes containing 10% of this functionalized polymer were formed and 
imaged under fluorescent microscopy before and after its exposure to a disulfide bond 
reducing agent such as TCEP. Here, a “selective” approach was attempted in order to 
stimulate the vesicle system to promote the release of a drug molecule in a reduction 
environment; the reducing agent was expected to selectively break down the disulfide 
bonds inside the functionalized polymer and release the attached fluorophore (which 
simulated a drug molecule) without disturbing the vesicle structure. Figure 5.2 shows a 
schematic description of the functionalized diblock copolymer synthesis and its 
reductive application once it was incorporated into vesicles. 
 
5.3 Materials 
PBd120PEO89 (MW 10400 g/mol) diblock copolymer and sucrose (ACS reagent) 
(C12H22O11, MW 342.3 g/mol) were purchased from Polymer Source Inc. (Canada) and 
Fisher Scientific (Pittsburgh, PA), respectively. Dichloromethane (anhydrous, 99.9%) 
(CH2Cl2, MW 84.93 g/mol), chloroform (99.8+% for analysis ACS, stabilized with 
ethanol) (CHCl3, MW 119.38 g/mol) and methanol (99.8+% for analysis ACS) (MeOH, 
MW 32.04 g/mol) were purchased from Acros Organics (Morris Plains, NJ). 
Tetrahydrofuran (≥ 99.0% ACS reagent) (THF, MW 72.11 g/mol), cystamine 
dihydrochloride (MW 225.20 g/mol) and tris(2-carboxyethyl)phosphine 
hydrochloride (TCEP, MW 286.65 g/mol) were purchased from Sigma-Aldrich (St. 
Louis, MO). 5-Carboxy-tetramethylrhodamine N-succinimidyl ester (5-TAMRA-
succinimidyl, MW 527.52 g/mol) was purchased from Fluka (Switzerland). 1-Ethyl-3-
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[3-dimethylaminopropyl]carbodiimide hydrochloride (EDC, MW 191.70) and N-
Hydroxysuccinimide (NHS, MW 115.09 g/mol) were purchased from Pierce (Rockford, 
IL). Regenerated cellulose dialysis tubing kit (MWCO 8000 g/mol) was purchased from 
Spectra/Por®Biotech and, the previously synthesized carboxylate PBd120-PEO89 diblock 
copolymer. 
 
5.4 Experimental Methods 
Diblock Copolymer Characterization 
IR Spectroscopy. IR spectra of neat liquids were performed using a Bruker FT-IR 
TENSOR™ spectrometer (Billerica, MA) equipped with OPUS™ measurement software. 
Potassium bromide salt plates (McCarthy Scientific Co., Fallbrook, CA) and CH2Cl2, or 
CHCl3, were used to evaluate the polymer samples. 
 
Vesicle Solution Characterization 
Cross-Polarizing Fluorescent Microscopy. Vesicle solutions were imaged using 
the temporary closed sample chamber described in Chapter III. Phase contrast images of 
polymersomes were taken by a Carl Zeiss Axiovert 200M inverted microscope with 100 
W HBO Mercury vapor lamp coupled to a Zeiss AxioCam MRm camera and a 20X 
objective (numerical aperture of 0.5). Fluorescent microscope images were obtained 
using a rhodamine band-pass filter with an excitation wavelength of 545 nm (bandwidth 
of 25 nm) and an emission wavelength of 605 nm (bandwidth of 70 nm). To facilitate 
comparison of samples to controls, all images were taken sequentially using the same 
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instrumental parameters and the recorded images were processed and analyzed 
identically with the program ImageJ. 
 
Treatment of Functionalized Vesicles with TCEP 
 10 μL of an equimolar solution of TCEP was added to the vesicle solution to be 
observed by fluorescent microscopy. The vesicle solution containing TCEP was gently 
stirred and allowed to react for 30 minutes before taking the images. 
 
5.5 Synthesis of PBd120PEO89-cystamine-5-TAMRA 
The reactions were conducted under an argon atmosphere and stirred using a 
Teflon-covered stir bar. A 5 mL reaction flask was charged with 1 mL of 1:1 
MeOH:CHCl3 solution, 10x10-3 mmol of cystamine dihydrochloride and 1x10-3 mmol of 
5-TAMRA-succinimidyl. The mixture was allowed to react for 8 hours at room 
temperature under constant magnetic stirring (900 rpm). After completion, 5-TAMRA-
succinimidyl is linked to cystamine at one of its ends only since it was present in excess 
amount. 1 mL (1x10-3 mmol) of 1:1 MeOH:CHCl3 solution of carboxylate PEO89-
PBd120, 10x10-3 mmol of EDC and 10x10-3 mmol of NHS were added to the reaction 
flask and allowed to react for 24 hours at room temperature under constant magnetic 
stirring (900 rpm). Extra doses of EDC and NHS were added every two hours to increase 
the amount of cystamine-5-TAMRA linked to carboxylate groups. 
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Synthesis of (6) 
5-carboxy-tetramethylrhodamine N-succinimidyl ester (1.54 mg, 2.92x10-3 
mmol) and cystamine dihydrochloride (3.29 mg, 14.62x10-3 mmol) were reacted in 
methanol/chloroform as described above. Product 6 was obtained but not purified and 
used to continue with the synthesis of 7. 
 
Synthesis of (7) 
Carboxylate PBd120-PEO89 (30.40 mg, 2.92 103mmol), EDC (5.60 mg, 
29.23103mmol), NHS (1.68 mg, 14.62 103  mmol) and product 6 were reacted in 
methanol/chloroform as described above. In this manner, product 7 (22.80 mg, 75% 
yield) was obtained. IR (ν): 1695 (C=O) cm-1, 1539 (N-H bend) cm-1. 
 
Synthesis of Diblock Copolymer Controls 
The modified diblock copolymers used in controls were prepared using different 
components and were labeled as follow: Control 1: when cystamine, 5-TAMRA-
succinimidyl, PBd120PEO89, EDC and NHS were combined; control 2: when cystamine, 
5-TAMRA-succinimidyl and carboxylate PBd120PEO89 were combined; sample: when 
cystamine, 5-TAMRA-succinimidyl, carboxylate PBd120PEO89, EDC and NHS were 
combined (Figure 5.3). 
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Figure 5.3 Schematic representations of controls and sample synthesis of functionalized 
PBd120PEO89-cystamine-5-TAMRA diblock copolymer. (A) Control 1: cystamine-5-TAMRA, 
EDC, NHS and unmodified PBd120PEO89; control 2: cystamine-5-TAMRA and carboxylate 
PBd120PEO89 and, sample: cystamine-5-TAMRA, EDC, NHS and carboxylate PBd120PEO89. (B) 
Final control and sample products incorporated into a polymersome.  
 
Functionalized Polymer Cleaning Procedure 
The desired product, was redisolved in 2 mL of a 1:1 MeOH:CHCl3 solution and 
cleaned using regenerated cellulose dialysis tubing (MWCO 8000 g/mol). The sample 
was dialyzed for 2 hours at room temperature against 600 mL (300 times the volume of 
the sample) of 1:1 MeOH:CHCl3 solution, the dialysis buffer was changed and the 
sample dialyzed for another 2 hours. Finally, the dialysis buffer was changed for the 
second time and the sample dialyzed overnight. 
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5.6 Vesicle Solution Preparation 
A polymer film containing 100 μg of the desired block copolymer or block 
copolymer mixture was formed by evaporation (8 hours) at the bottom of a 5 mL glass 
scintillation vial. Polymersomes were formed by rehydration of this polymer film during 
24 hours at 60ºC with 2 mL of 300 mOsm/kg sucrose solution. A vesicle solution of the 
following mixture composition was formed: 10% w/w of PBd120PEO89-cystamine-5-
TAMRA and 90% w/w of unmodified PBd120PEO89. The final block copolymer 
concentration in a vesicle solution of 2 mL is 4.8 μM. 
 
Vesicle Solution Controls 
Two vesicle solutions of controls were prepared by combining in a 9:1 ratio the 
unreacted PBd120PEO89 and the functionalized diblock copolymer control 1 or control 2. 
 
5.7 Results and Discussion 
IR Results from Amination Reaction 
 Figure 5.4 shows the overlay IR spectra of the carboxylate PBd120PEO89 (top) 
and PBd120PEO89-cystamine-5-TAMRA-succinimidyl (bottom). The presence of a 
carbonyl stretch peak at around 1695 cm-1 and N-H bend peak at 1456 cm-1 demonstrates 
the formation of a peptide linkage between the primary amines (cystamine and 5-
TAMRA-succinimidyl) and the carboxylate PBd120PEO89. 
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Figure 5.4 Comparison between the IR spectra of the unmodified carboxylate PBd120PEO89 (top) 
and the covalent coupling reaction product, PBd120PEO89-cystamine-5-TAMRA (bottom). 
 
Imaging Results of Functionalized PBd120PEO89-cystamine-5-TAMRA Vesicles 
 Figure 5.5 and Figure 5.6 show three vesicle samples obtained by using 
unmodified PBd120PEO89 and PBd120PEO89-cystamine-5-TAMRA block copolymer 
previously synthesized in a 9:1 ratio. Figure 5.5(A) shows red fluorescent vesicles which 
confirm that 5-TAMRA-succinimidyl is linked to the carboxylate PEO89-PBd120 through 
the proposed amination reaction. Figure 5.5(B) shows their respective intensity profiles 
with an average peak intensity of 192.7 units (standard deviation of 30.6 units).  
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Figure 5.5 Images of fluorescent block copolymer vesicles made with unreacted PBd120PEO89 
and PBd120PEO89-cystamine-5-TAMRA mixed in a 9:1 ratio before exposure to TCEP. (A) 
Fluorescent images taken using a rhodamine filter. (B) Intensity profiles corresponding to each 
fluorescent vesicle shown in A.  
 
Table 5.1 Intensity profile values of PBd120PEO89-cystamine-5-TAMRA functionalized vesicles 
before and after exposure to TCEP. Average values of bilayer peak 1 and 2 of five different 
samples are shown and compared and in all cases, a decrease in the fluorescence intensity was 
registered after exposure to TCEP. 
 
 Functionalized Vesicle 
Functionalized Vesicle After 
Exposure to TCEP 
 (Intensity units) (Intensity units) 
 
Peak 1 Peak 2 Average Peak 1 Peak 2 Average 
  
Trial 1 190.2 207.5 198.9 72.9 92.8 82.8 
Trial 2 170.1 189.4 179.7 103.0 102.5 102.8 
Trial 3 203.5 212.8 208.2 120.5 139.6 130.1 
Trial 4 225.0 232.3 228.6 148.5 128.9 138.7 
Trial 5 146.7 149.0 147.8 82.0 89.7 85.9 
StDev     30.6     25.4 
Distance (pixels) 
 85 
Figure 5.6(A) shows three different vesicle samples after addition of TCEP to the 
vesicle solution while Figure 5.6(B) shows their respective intensity profiles with an 
average peak intensity of 108.0 units (standard deviation of 25.4 units).  Individual 
vesicles exhibit lower fluorescence intensity after exposing the vesicle solution to TCEP. 
Tables 5.1 and 5.2 show the average intensity profile values of bilayer peaks 1 and 2 and 
the fluorescent intensity percentage decrease of five functionalized vesicles before and 
after addition of TCEP. 
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Figure 5.6 Images of fluorescent block copolymer vesicles made with unreacted PBd120PEO89 
and PBd120PEO89-cystamine-5-TAMRA mixed in a 9:1 ratio after exposure to TCEP. (A) 
Fluorescent images taken using a rhodamine filter. (B) Intensity profiles corresponding to each 
fluorescent vesicle shown in A.  
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Vesicles formed in a 9:1 ratio with unreacted PBd120PEO89 and PBd120PEO89-
cystamine-5-TAMRA polymers show a difference in the fluorescence intensities before 
and after treating the vesicle solutions with TCEP. A 44% decrease in fluorescence 
intensity was recorded after a change in the polymersome environment. This difference 
is attributed to the selective reduction of disulfide bonds present in the PBd120PEO89-
cystamine-5-TAMRA block copolymer. When the disulfide bonds are broken, 5-
TAMRA is released and lower fluorescent intensity was observed in the vesicle‟s 
bilayer. However, it is not determined if the fluorophore was released into the aqueous 
solution or if it was partially redisolved into the vesicle‟s bilayer. 
 
Table 5.2 Average intensity profile values of PBd120PEO89-cystamine-5-TAMRA functionalized 
vesicles before and after exposure to TCEP of 5 different samples. A 44% decrease in 
fluorescence intensity was recorded after a change in the polymersome environment was 
produced. 
 
 Functionalized 
Vesicle 
Functionalized Vesicle 
After Exposure to TCEP % Intensity 
decrease 
 
 
 (Intensity units) (Intensity units) 
Trial 1 198.9 82.8 58.3 
Trial 2 179.7 102.8 42.8 
Trial 3 208.2 130.1 37.5 
Trial 4 228.6 138.7 39.4 
Trial 5 147.8 85.9 41.9 
Average 192.7 108.0 43.9 
StDev 30.6 25.4 8.3 
 
5.8 Conclusions 
 The functionalized reductive-responsive diblock copolymer PBd120PEO89-
cystamine-5-TAMRA was synthesized using a one-pot two-step reaction and has been 
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incorporated into polymersomes with a 10% amount. A fluorophore was attached at the 
end of the diblock for imaging purposes but virtually any suitable drug molecule can 
replace it and be carried by a polymersome. 
 The reductive character of the diblock was given by the presence of a disulfide 
linkage between the PEO block and the fluorophore molecule. When PBd120PEO89-
cystamine-5-TAMRA functionalized polymersomes were formed, the reductive 
character of this new diblock was preserved in the vesicle‟s configuration.  
 Functionalized vesicles were exposed to a reducible environment by the addition 
of TCEP. The diblock copolymer disulfide bonds were selectively reduced and the 
fluorophore 5-TAMRA was released into solution. Fluorescent microscopy showed that 
the vesicle‟s bilayer fluorescent intensity decreased by 44 % and, we can infer from this 
result that about 44% of the attached 5-TAMRA was released. 
 These stimuli-responsive vesicles can be used as reliable drug delivery carriers 
that at the encounter of the cell‟s cytoplasm, which is characterized as a reductive 
environment, will break the susceptible bonds and release the transported drug 
molecules. 
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CHAPTER VI 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
6.1 Conclusions 
We proved that the primary alcohol end group of the PBd120PEO89 diblock 
copolymer can be chemically modified and effectively combined with unmodified 
PBd120PEO89 to form stable functionalized polymeric vesicles. The free hydroxyl 
terminal group of the PEO block was first oxidized to its corresponding carboxylic acid 
through a regioselective one-pot two-phase oxidation reaction while other oxidizable 
groups present in the diblock copolymer backbone remained unaffected. Subsequently, 
three primary amines (two fluorophores and a hormone molecule) were able to be 
covalently attached to the previously synthesized carboxylate diblock through a 
modified coupling reaction performed in organic phase (Chapter III). 
Polymersomes containing 90% of the unmodified PBd120PEO89 diblock 
copolymers and 10% of one of the modified diblock copolymers (PBd120PEO89-6AF, 
PBd120PEO89-COU and PBd120PEO89-NA) has been prepared. In addition, the two 
fluorescently modified diblock copolymers (PBd120PEO89-6AF and PBd120PEO89-COU) 
have been properly integrated into the same vesicle, and surface density control of the 
two fluorophores was achieved suggesting that these drug delivery prototypes can be 
tailored (Chapter IV). 
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The measured CAC values of vesicle solutions containing a mixture of 
carboxylate PBd120PEO89 and unmodified PBd120PEO89 were found to increase as the 
carboxylate PBd120PEO89 content increased, in the meantime the average vesicle size 
decreased. This observation suggests that the carboxylic acid group lowered the 
polymer‟s ability to be incorporated into a polymersome when present in concentrations 
higher than 80 percent. 
In Chapter IV, RASMC essays reveal that hormone functionalized polymeric 
vesicles (containing NA) were able to deliver the hormone molecules that are carried at 
the vesicle‟s surface. It was confirmed by the increase in the cells‟ fluorescent intensity 
after placing a functionalized vesicle in close contact with the cell‟s surface.  
As discussed in Chapter V, a rhodamine functionalized diblock copolymer 
containing a disulfide linkage between the PEO block and the fluorophore (PBd120-
PEO89-cystamine-5-TAMRA) has been synthesized. This reducible functionalized 
polymer, specifically designed to be susceptible to disulfide bond cleavage when 
exposed to a reducing environment, was effectively integrated into a polymersome. The 
disulfide moiety has show to be selectively reduced when exposed to a change in the 
surrounding conditions promoted by the addition of the reducing agent TCEP. The 
fluorophore was released into solution indicating that these polymersomes can be used 
as stimuli responsive drug delivery carriers. 
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6.2 Future Directions 
For future studies, the diblock copolymer used may be substituted by a 
biodegradable one and apply to it the synthesis explored during this research. 
Functionalized biodegradable polymersomes, their cell internalization and degradation 
time can be systematically investigated in order to elucidate their response mechanism. 
Hormone functionalized vesicles might be further studied to better understand 
the cell‟s response, drug internalization, drug release profiles and long distance 
intracellular communication. Also, stimuli-responsive functionalized polymersomes 
vulnerable to reducible atmospheres might be evaluated in contact with RASMC cultures 
to establish the reductive strength of the cytoplasmic environment over the disulfide 
moieties employed. 
Vesicle solutions containing 10% w/w PBd120PEO89-cystamine-5-TAMRA 
reducible functionalized diblock copolymer and 90% w/w PBd33PEO20 (a shorter 
diblock, MW 2700 g/mol) might be formed and evaluated in order to enhance the 
availability of the functionalized polymer to TCEP by preventing polymer 
entanglements.  
A reductive destabilization mechanism involving a phase transition from vesicle 
to micelle may also be investigated. A PEO-PBd diblock copolymer linked to a second 
PEO block by a cystamine molecule can be synthesized and polymersomes containing 
this PEO-PBd-cystamine-PEO amphiphillic polymer might be formed. The reduction of 
the disulfide moiety present in cystamine by TCEP may induce a morphological change 
from highly stable vesicles to micelles (Figure 6.1). This change in surface topology, in 
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response to a change in the environment character, may be useful to create a stimuli 
responsive drug delivery vehicle. 
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Figure 6.1 Schematic representation of the two-step synthesis of functionalized PBdmPEOn-
cystamine-PEO(m-n) block copolymer and its possible function as a stimuli responsive reducible 
component. (A) Formation functionalized diblock by covalent coupling reaction. (B) Exposure 
of functionalized polymersome to reducing agent might cause breakage of disulfide bonds. (C) 
Functionalized polymersome encapsulating drug molecules (represented by red stars) may 
experience a morphological change from vesicle to micelles causing control release of 
transported molecules when exposed to a reducing environment.  
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